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Abbreviations
BCA bicinchoninic acid
BHK baby hamster kidney
BSA bovine serum albumin
ELISA enzyme-linked immunosorbent assay
FF fast flow
HA hemagglutinin
a-HBs antibody against Hepatitis B surface antigen
hCG human chorionic gonadotrophin
HIV human immuno deficiency virus
HRP horse radish peroxidase
HPLC high pressure liquid chromatography
H PSEC high performance size exclusion chromatography
IgG immunoglobulin of class G
NHS N-hydroxysuccinimide
Mab, Mca monoclonal antibody
OT Organon Teknika
PAG polyacrylamide gel
PAG E polyacrylamide gel electrophoresis
Ru, Rub rubella
RV rubella virus
SP IA sol particle immunoassay
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CHAPTER 1
General introduction
1. Principle of bioaffinity chromatography
In this thesis the term bioaffin ity chromatography stands for a type of adsorption 
chromatography which is based on a specific and reversible interaction of a biologically 
functional pair of molecules, e.g. antibody and antigen, and bacterial Ig Fc receptors (e.g. 
protein A) and immunoglobulines. More examples of such biologically functional pairs are 
listed in Table 1.
The bioaffin ity interaction  between these molecules is a complex of stereospecific 
factors and concurrent physico-chemical forces such as, ionic bonds (coulombic attraction of 
oppositely charged ionized groups), hydrophobic interactions (involving nonpolar groups), 
hydrogen bonds (between suitable proton donors and acceptors), Van der Waals forces, 
dipole-dipole interactions and charge-transfer interactions.
Table 1 Examples o f biologically functional pairs o f molecules used in bioaffinity chromatography.
Hormone Receptor
Enzyme Co-factor, inhibitor, substrate analogue
Antibody Antigen, protein A or ß-galactosidase fusion products, virus, cell
Bacterial Ig Fc receptor Immunoglobulin
Lectins Glycoprotein, cell surface receptor, membrane protein, cell
Nucleic acid Complementary nucleic acid
Nucleotide Nucleic acid-binding protein
Carbohydrate Lectin, enzyme or other sugar binding protein
Biotin Avidin or streptavidin
Vitamin Carrier protein
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One of the members of the biologically functional pair of molecules, the ligand, is 
immobilized onto a solid phase which gives a so-called adsorbent or affin ity matrix. The 
other, the biomolecule to be purified from the crude extract, is adsorbed onto the affinity 
matrix. Next, the affinity matrix is washed thoroughly to remove (i) all the compounds which, 
under given experimental conditions, have no bioaffinity interaction with the ligand, and (ii) all 
remaining non-specifically bound compounds. The bound biomolecule is desorbed from the 
column by a solution of a soluble affinity ligand or, more frequently, by changing the solvent 
composition e.g. by a change in pH, ionic strength or temperature, or alternatively, by a 
solution containing chaotropic agents such as urea, guanidine, thiocyanate, or detergents. 
It is important to use conditions which promote the dissociation of the complex without 
destroying either the biomolecule to be purified or the ligand. Finally, the affinity matrix is 
regenerated and re-equilibrated to prepare it for reuse in another cycle of operation. This 
bioaffinity chromatographic process may occur in a batch system, a fixed bed, a 
countercurrent bed or in a fluidized bed. A schematic drawing of the principle of the 
bioaffinity chromatographic process is given in Figure 1.
Preparative bioaffinity chromatography is a very powerful method. It is the method of 
choice when the target biomolecule is a minor component in a usually expensive and 
complex biological mixture. A bioaffinity chromatographic process is characterized often by
(i) a concentrating effect, enabling large volumes to be conveniently processed (ii) being a 
single step process, allowing immense time-saving over less selective multi-stage processes 
(iii) purification factors of the order of several ten thousand-fold, and (iiii) generally very high 
recoveries of active material.
2. Nomenclature
In 1968, Cuatrecasas et al. [1,2] used the term "affinity chromatography" for the first 
time. Unfortunately, this name is not very descriptive for the process and the term is used
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Figure 1 The principle o f the bioaffinity chromatographic process: (I) The ligand is immobilized 
onto a solid support, which gives the affinity matrix. (II) The crude extract is incubated with the affinity 
matrix. (III) The target molecule for which the ligand posesses bioaffinity is bound. (IV) The impurities 
are removed by washing. (V) The bound biomolecule is desorbed. (VI) The affinity matrix is prepared 
for reuse.
with quite different meanings by different authors. Sometimes it is very broad including all 
kinds of adsorption chromatographies based on non-traditional ligands, in the extreme case 
all chromatographies except ion exchange. Often it is meant to include immobilized metal ion 
affinity chromatography, covalent chromatography, hydrophobic interaction chromatography, 
biomimetic ligand (dye) chromatography, etc. In other cases it refers only to ligands which 
are members of a biologically functional pair of molecules, such as enzyme-inhibitor or 
enzyme-substrate, avidin-biotin, and antibody-antigen complexes.
Several terms have been employed to emphasize that the affinity is based on 
biospecific interactions: for example, "biospecific adsorption chromatography" [3], "bioaffinity 
chromatography" [4,5], "bioselective adsorption chromatography" [6], "ligand specific 
chromatography" [7] and "bio-specific affinity chromatography" [8]. Regardless of the term
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preferred, it should be borne in mind that distinguishing between a complex based on a 
biospecific interaction and a complex based on non-specific (e.g. hydrophobic) forces is not 
always a simple task as has been observed in many instances (see also chapter two of this 
thesis). Examples of affinity chromatographic processes based on non-biological interactions 
are listed in Table 2.
The section of bioaffinity chromatography based on antigen-antibody interactions, 
called imm unosorption or im m unoaffinity chromatography, has been so successful that it is 
often treated separately.
In this thesis the term "bioaffinity chromatography" is used together with the more 
specific terms "immunoaffinity chromatography" and "protein A affinity chromatography".
3. History of bioaffinity chromatography
The first application of a separation based on a bioaffinity interaction was the isolation 
of a-amylase by means of an insoluble substrate (starch), described by Starkenstein [9] in 
1910. The principle of bioaffinity chromatography, using affinity ligands covalently bound to a 
solid support, has been known since 1951. The purification of antibodies using a column of 
cellulose-bound antigen, described by Campbell et al. [10], was the first application based on 
this principle. In 1953, Lerman [11] was the first to use bioaffinity chromatography in the 
isolation of enzymes. He described the isolation of tyrosinase on a column of cellulose with 
immobilized resorcinol residues. In the next years bioaffinity chromatography was used only 
sporadically. The main reasons for this were (i) the type of supports available, which did not 
offer sufficient possibilities for the formation of the complex and the attached ligand, and 
which often showed non-specific adsorption due to hydrophobic or ionogenic groups;
(ii) the complex organic chemistry required to synthesize a reliable matrix and to attach 
ligands covalently.
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Table 2 Examples o f non-biological interactions used in affinity chromatography.*
Covalent chromatography
SH-groups
Papain, creatine phosphokinase, cysteine-tailed recombinant DNA fusion proteins
Boronate matrix affinity chromatography
Boronic acid groups
cis-Diol groups containing compounds: ribonucleotides, glucosylated proteins
Hydrophobic interaction chromatography (HIC)
Hydrophobic groups: methyl, propyl, butyl, octyl and phenyl 
Enzymes, hormones and other proteins
Immobilized metal chelate affinity chromatography (IMAC)
Chelating groups: iminodiacetic acid (IDA), tris(carboxymethyl)ethylenediamine (TEMED),
ethylenediaminetetraacetic acid (EDTA), hydroxamic acids 
Nucleosides, enzymes and other proteins
Charge transfer chromatography
Charge transfer groups: acriflavine, acridine yellow, trityl group, pentachlorophenol, malachite green 
Separation of single-stranded nucleic acids (adsorbed) from double-stranded nucleic acids, 
(oligo)nucleotides and a wide variety of aromatic compounds
Thiophylic interaction chromatography
Sulfur atom containing groups: thioether or sulfone-thioether groups 
Immunoglobulins
Immobilized dye affinity chromatography
Dyes: Cibacron Blue F3G-A, Procion Red HE-3B
Enzymes and other proteins (albumin, interferon, blood coagulation factors II and IX and 
plasminogen)
Molecular imprinting chromatography
Cavities, formed by polymerization of gel monomers around the print molecule 
Low molecular weight compounds
* For specific details see review articles and books at the end of this section
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However, it was considered a milestone in the development of the use of bioaffinity 
chromatography when Axen, Porath and Ernback [12,13] in 1967 reported that molecules 
containing primary amino groups could be coupled to polysaccharide matrices activated by 
cyanogen bromide. It was shown by Cuatrecasas and Anfinsen [14] that "beaded" agarose 
displays virtually all the characteristics required for a successful matrix for immobilizing 
biologically active molecules.
Until 1984 [15] the same carriers, basically an agarose, and the same activating 
reagent, cyanogen bromide, remained the predominant means for the preparation of affinity 
matrices. Non-specific interactions due to ion-exchange and hydrophobic interactions [16], 
and leakage of ligand from the carrier due to the unstable isourea linkage [17,18,19,20], 
however, are disadvantages of CNBr-activated matrices. For many protein ligands, the 
coupling is rapid and efficient, and a relatively stable bond is obtained by multi-point 
attachment. Consequently, this CNBr activation is still a frequently used method for coupling 
ligands.
A more widespread use of bioaffinity chromatography has been achieved by (i) the 
development and application of "spacer" molecules between ligand and matrix, which 
decreases the steric hindrance during formation of the complex, (ii) the development of 
alternative matrices, which have a higher porosity, show a higher thermal, chemical and 
mechanical stability and lower non-specific adsorption, and (iii) the development of new 
methods for the preparation of activated solid supports, which makes the immobilization of 
ligands through different functional groups possible. As a result of these developments 
nowadays a wide variety of affinity matrices and stable ready-to-use activated solid supports 
for immobilization of ligands through different functional groups are available.
There are numerous bioaffinity purification protocols described in the literature. For a 
detailed description of these procedures and a discussion of the crucial factors see the 
following (review) articles: Cuatrecasas and Wilcheck 1968 [2], Wilchek et al. 1984 [15], 
Liapis 1991 [21], Lowe 1991 [22,25], Jones 1991 [23], McCoy 1991 [24], Winzor 1992 [26],
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Jack  1994 [27], Narayanan 1994 [28], Harakas 1994 [29], Liapis and Unger 1994 [30], 
Goward 1995 [31], Jack  and Beer 1996 [32], Cutler 1996 [33] and books: Lowe and Dean 1974 
[34], Turkova 1978 [35], Scouten 1981 [36], Gribnau et al. 1982 [37], Dean et al. 1985 [38], 
Harlow and Lane 1988 [39], Carlsson et al. 1989 [40], Hermanson et al. 1992 [41], Pharmacia 
1993 [42], Kline 1993 [43], Kenney and Fowell 1992 [44] and Turkova 1993 [5].
4. Objectives and scope of the thesis
Technical problems that must be taken into account while setting up a preparative 
bioaffinity-based separation procedure are the following.
• The choice of the solid phase material, ligand and ligand-linking to the support.
• The need to preserve the integrity of the biomolecule to be purified and of the ligand.
• The specificity of the procedure and the specific activity of the final product.
• The possible introduction of endotoxins, bacterial or viral contamination, residual DNA 
and leakage of soluble solid-phase fragments and ligands.
• The regeneration and reusability of the affinity matrix.
The objectives of the work described in this thesis were to investigate several of 
these technical problems for protein A affinity chromatography and immunoaffinity 
chromatography, more specifically:
(i) the investigation of various aspects concerning the purification of mouse monoclonal IgG1 
antibodies using protein A affinity chromatography, (ii) the selection of an activated matrix for 
the preparation of an immunoaffinity matrix, and (iii) the development of immunoaffinity 
based purification procedures for anti-hCG antibodies from hen's egg yolk and rubella virus 
E1-E2 membrane proteins.
Chapter two describes how the composition of the binding buffer, with respect to 
concentration and type of ion, affects the binding of mouse monoclonal IgG1 antibodies to
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immobilized protein A. The effects of temperature and flow rate on the binding capacity of 
protein A Sepharose 4 fast flow were also investigated.
The set-up of a model study to determine the extent to which cross-contamination 
occurs when the same protein A column is used to purify different mouse monoclonal 
antibodies is treated in chapter three.
Chapter four accounts for the extent to which the coupling performance of a mouse 
monoclonal antibody onto an agarose matrix is affected by the type of coupling chemistry, 
and how the immunoaffinity matrices obtained differ with respect to ligand leakage and 
binding capacity.
The immunoaffinity purification of rubella virus E1-E2 membrane protein complexes 
from extracts of cell culture supernatants is described in chapter five. After investigation of 
the effect of ligand density on adsorption behaviour of the immunosorbent, the 
immunoaffinity purification process was optimized with regard to adsorption efficiency by 
adjustment of the flow rate, the bed height and the amount of sample loaded onto the 
column.
Chapter six deals with the isolation and purification of immunoglobulins against human 
chorionic gonadotrophin from hen's egg yolk by immunoaffinity chromatography.
5. References
1 P. Cuatrecasas, M. Wilcheck and C. Anfinsen, Selective enzyme purification by affinity 
chromatography, Proc. Nat. Acad. Sci. U.S.A., 61 (1968) 636-643.
2 P. Cuatrecasas and M. Wilcheck, Single-step purification of avidin from egg white by affinity 
chromatography on biocytin-sepharose columns, Biochem. Biophys. Res. Commun., 33 (1968) 
235-239.
3 J. Porath, Biochemie, 55 (1973) 943-951.
4 P. O'Carra, Biochem. Soc. Trans., 2 (1974) 1289-1293.
5 J. Turkova, Bioaffinity Chromatography in Journal o f Chromatography Library, Elsevier, 
Amsterdam, The Netherlands, Vol. 55 (1993) 1-796.
6 W. Scouten, Am. Lab., 6 (1974) 23.
- 16 -
Introduction
7 S. May and O. Zarborsky, Separation and Purification Methods, Marcel Dekker Inc., Vol. 3 
(1974).
8 J. Porath and T. Kristiansen in: The Proteins, H. Neurath and R. Hill (Editors), Academic Press, 
New York, Vol. 1 (1975) 95.
9 E. Starkenstein, Biochem. Z , 24 (1910) 210-218.
10 D. Campbell, E. Luescher and L. Lerman, Immunologic adsorbents. I. Isolation of antibody by 
means of a cellulose-protein antigen, Proc. Nat. Acad. Sci. U.S.A., 37 (1951) 575-578.
11 L. Lerman, A biochemically specific method for enzyme isolation, Proc. Nat. Acad. Sci. U.S.A., 
39 (1953) 232-236.
12 R. Axen, J. Porath and S. Ernback, Chemical coupling of peptides and proteins to 
polysaccharides by means of cyanogen halides, Nature, 214 (1967) 1302-1304.
13 J. Porath, R. Axen and S. Ernback, Chemical coupling of proteins to agarose, Nature, 215 
(1967) 1491-1492.
14 P. Cuatrecasas and C. Anfinsen, Affinity chromatography, Methods Enzymol, 22 (1971) 
345-378.
15 M. Wilcheck, T. Miron and J. Kohn, in Methods in Enzymology, S. Colowick and N. Kaplan 
(Editors), Enzyme Purification and Related Techniques Part C, W. Jakoby (Editor), Vol. 104 
(1984) 3-55.
16 R. Jost, T. Miron and M. Wilchek, Bioch. Biophys. Acta, 362 (1974) 75.
17 G. Tesser, H. Fisch and R. Schwyzer, Limitations of Affinity Chromatography: Sepharose-Bound 
Cyclic 3',5'-Adenosine Monophosphate, FEBS Letters, 23 (1972) 56-58.
18 G. Tesser, H. Fisch and R. Schwyzer, Limitations of Affinity Chromatography: Solvolytic 
Detachment of Ligands from Polymeric Supports, Helv. Chim. Acta, 57 (1974) 1718-1730.
19 T. Oka and Y Topper, Proc. Natl. Acad. Sci U.S.A., 71 (1974) 1630-1633.
20 M. Wilchek, T. Oka and Y Topper, Proc. Natl. Acad. Sci U.S.A., 72 (1975) 1055.
21 A. Liapis, Biospecific adsorption-mechanisms and processes of affinity chromatography, 
Conference proceedings: Int. Conf. Fundam. Adsorpt. 3rd, AIChE, New York, (1991) 25-61.
22 C. Lowe, Affinity chromatography: principles and applications, in NATO ASI Ser, Ser E, 
Chromatographic and Membrane Processes in Biotechnology, C. Costa and J. Cabral (Editors), 
Kluwer Academic Publishers, The Netherlands, Vol. 204 (1991) 289-296.
23 K. Jones, Affinity Chromatography: A Technique for the 1990s, LC-GC, Vol 4, nr 9, (1991)
32-37.
24 B. McCoy, Theory of affinity chromatography, in NATO ASI Ser, Ser E, Chromatographic and 
Membrane Processes in Biotechnology, C. Costa and J. Cabral (Editors), Kluwer Academic 
Publishers, The Netherlands, Vol. 204 (1991) 297-308.
- 17 -
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
Chapter 1
C. Lowe, Affinity chromatography: design of biospecific chromatographic materials, in NATO ASI 
Ser, Ser E , Chromatographic and Membrane Processes in Biotechnology, C. Costa and
J. Cabral (Editors), Kluwer Academic Publishers, The Netherlands, Vol. 204 (1991) 353-361.
D. Winzor, Review: Recent developments in quantitative affinity chromatography, Journal of 
chromatography, Vol. 597 (1992) 67-82.
G. Jack, Immunoaffinity chromatography, in Applied Biochemistry and Biotechnology, part B: 
Molecular Biotechnology, Vol 1 (1994) 59-86.
S. Narayanan, Review: Preparative affinity chromatography of proteins, Journal of 
Chromatography A, 658 (1994) 237-258.
N. Harakas, Biospecific Affinity Chromatography, in Bioprocess Technology, Vol. 18 (1994) 
pp. 259-316.
A. Liapis and K. Unger, The chemistry and engineering of affinity chromatography, Conference 
Proceedings, Highly Sel. Sep. Biotechnol., Blackie, Glasgow, United Kingdom (1994) 121-162.
C. Goward, Affinity Chromatography and its Applications in Large-Scale Separations, in Process 
Scale Liquid Chromatography, VCH, Weinheim, Germany, (1995) pp. 193-214.
G. Jack and D. Beer, Immunoaffinity chromatography, in Methods in Molecular Biology,
J. Walker (Editor), The Humana Press Inc., Totowa, NJ, USA, Vol. 59 (1996) pp. 187-196.
P. Cutler, Affinity Chromatography, in Methods in Molecular Biology, J. Walker (Editor),
The Humana Press Inc., Totowa, NJ, USA, Vol. 59 (1996) pp. 157-168.
C. Lowe and P. Dean, Affinity Chromatography, John Wiley & Sons, London, United Kingdom, 
(1974).
J. Turkova, Affinity Chromatography, in Journal o f Chromatography Library, Elsevier,
Amsterdam, The Netherlands, Vol. 12 (1978).
W. Scouten, Affinity Chromatography, Bioselective Adsorption on Inert Matrices, in Chemical 
Analysis, P. Elving, J. Winefordner and I. Kolthoff (Editors), John Wiley & Sons, New York, USA, 
Vol. 59 (1981).
T. Gribnau, J. Visser and R. Nivard (Editors), Affinity Chromatography and Related Techniques, 
Elsevier, Amsterdam, The Netherlands, (1982).
P. Dean, W. Johnson and F. Middle (Editors), Affinity Chromatography: A Practical Approach;
IRL Press, Oxford, United Kingdom, (1985).
E. Harlow and D. Lane, Antibodies: A Laboratory Manual, Cold Spring Harbor (NY) Press,
(1988).
J. Carlsson, J. Janson and M. Sparrman, Affinity Chromatography, in Protein Purification: 
Principles, High Resolution Methods and Applications, J. Janson and L. Ryden (Editors),
VCH Publishers, Cambridge, United Kingdom, (1989) pp. 272-329.
- 18 -
Introduction
41 G. Hermanson, A. Krishna Mallia and P. Smith (Editors), Immobilized Affinity Ligand 
Techniques; Academic Press, London, United Kingdom, (1992).
42 Pharmacia, Affinity Chromatography: Principles and Methods; Handbook published by 
Pharmacia LKB Biotechnology AB, Uppsala Sweden, (1993).
43 T. Kline (Editor), Handbook of Affinity Chromatography, in Chromatographic Science Series,
J. Cazes (Editor), Marcel Dekker, New York, USA, Vol. 63 (1993).
44 A. Kenney and S. Fowell (Editors), Practical Protein Chromatography, in Methods in Molecular 
Biology, J. Walker (Editor), The Humana Press Inc., Totowa, NJ, USA, Vol. 11 (1992) pp. 1-327.
- 19 -
- 2G -
CHAPTER 2
Effects of temperature, flow rate and composition of binding buffer 
on adsorption of mouse monoclonal IgG1 antibodies to 
protein A  Sepharose 4 fast flow
A.P.G. van Sommeren, P.A.G.M. Machielsen and T.C.J. Gribnau 
Preparative Biochemistry, Vol. 22, no. 2 (1992) 135-149
ABSTRAC T
The binding capacity of protein A Sepharose 4 fast flow for mouse IgG1 monoclonal 
antibodies (mabs) appears to be highly dependent on the buffer composition with respect to 
both concentration and ion type. Depending on the particular mab dynamic binding 
capacities up to 20 mg mab per ml gel could be obtained, when these mabs were isolated 
from supernatants of protein free hollow fibre cell culture systems.
Variation of linear flow rate from 10 up to 300 cm/h and temperature (4°C versus 25°C) had 
a slight effect on the dynamic binding capacity, when a high ionic strength buffer was used 
during adsorption.
Applying optimum binding conditions, final IgG fractions with a purity of more than 95% 
monomeric IgG were obtained. However, as side effect of the use of binding buffers with 
high ionic strength, the binding of acid proteases was also promoted.
Copyright © 1992 by Marcel Dekker, Inc.
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1. INTRODUCTION
The purification of immunoglobulins (IgG), in particular mouse monoclonal antibodies 
(mabs), using affinity chromatography with protein A as ligand is very popular because of its 
simplicity, speed and efficiency. For most mouse mabs of the IgG1 subclass however, the 
binding affinity is very weak. As the majority of mouse mabs are of the IgG1 subclass, there 
has been a strong interest in finding conditions under which the binding affinity and recovery 
of immunoreactive mouse IgG1 from protein A can be maximized.
It is assumed that binding between IgG1 and protein A is at least partly based on 
hydrophobic interactions1 so that conditions which favour these interactions should also 
enhance the binding of IgG1 to protein A. Accordingly it was described that increasing the pH 
and/or the ionic strength of the binding buffer enhances the affinity of these mabs for 
protein A2,3,4.
When adsoption buffers of relatively low ionic strength are used, improvement of the 
binding of IgG1 antibodies to protein A can also be obtained by lowering the temperature as 
described by Nustad et a .5 and Tu et al.6. Also, flow rate and column dimensions play a 
major role in optimizing the dynamic binding capacity for a particular adsorbent bed volume. 
Increased residence time for the antibodies in the protein A column leads to better binding 
capacity. Effects of flow rate and column dimensions on binding capacity of protein A 
Sepharose 4 fast flow for human IgG have been described in the literature7.
The mouse mabs used in these investigations were directed against human chorionic 
gonadotrophin (hCG) or human immune deficiency virus (HIV) and all were of the IgG1 
subclass. Development of hybridomas and production of mabs under protein free conditions 
in haemodialysis hollow fibre modules were performed as described by Schonherr et a l8,9.
In this paper it is described in which way the composition of binding buffer 
(concentration and ion type) affects purification of these mouse IgG1 mabs with respect to 
the dynamic binding capacity of the protein A Sepharose 4 fast flow gel, and the purity of the 
final IgG solution (monomeric IgG content and contamination with proteolytic enzymes).
- 22 -
Purification of mouse IgG 1 monoclonal antibodies using Protein A affinity chromatography
It is also described how flow rate and temperature affect the dynamic binding capacity of the 
gel when a buffer with relatively high ionic strength is used during adsorption.
2. EXPER IM EN TA L
2.1 Chemicals
Mabs OT-hCG-1C, 4D, 3A, 6A and 7B and OT-HIV-4A and 4B were produced under 
protein free conditions in hollow fiber dialysis systems. Some general characteristics of these 
mabs and their corresponding starting materials are given in Table I. Protein A Sepharose 4 
fast flow and Ampholine PAG plates were purchased from Pharmacia/LKB. Protease 
Substrate Gel Tablets and diffusion plates were from BioRad. Bovine spleen cathepsin D 
(13 U / mg protein; haemoglobin as substrate) was obtained from Sigma (St. Louis, U.S.A.). 
The Zorbax Bio Series GF-250 column with dimensions: 0 9.44 mm, h 250 mm was 
supplied by DuPont de Nemours B.V. All other chemicals were of analytical reagent grade 
quality.
Table I Characteristics o f the Mab Starting Materials.
Mab code Sub­
class
Isoelectric Point 
pH-range > IgG
Purity (%)* 
= IgG < IgG
IgG content 
mg / ml
OT-hCG-1C IgG1 5.6 -6.5 5.6 55.2 39.2 2.0
OT-hCG-4D IgG1 6.5 -7.1 6.9 91.6 1.5 14.5
OT-hCG-3A IgG1 6.6 -7.2 8.1 75.2 16.7 4.0
OT-hCG-6A IgG1 5.5 -5.9 7.1 75.0 17.9 5.9
OT-hCG-7B IgG1 5.4 -5.8 1.6 92.1 6.3 3.0
OT-HIV-4A IgG1 5.2 -6.8 8.0 48.0 44.0 2.5
OT-HIV-4B IgG1 5.2 -6.8 13.2 69.3 17.5 2.5
* Purity based on High Performance Size Exclusion Chromatography: 
(> IgG) protein with a molecular mass higher than IgG 
(= IgG) protein with the molecular mass of IgG 
(< IgG) protein with a molecular mass lower than IgG.
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2.2 Equipment
The low pressure liquid chromatography system was supplied by Pharmacia/LKB and 
consisted of a P-1 peristaltic pump, a UV-2 monitor, a pH/ion monitor, a FRAC-200 fraction 
collector and a flat bed recorder. The HPLC system consisted of an LKB 2150 pump, an 
LKB 2151 detector, an LKB 2152 controller, a Spectra Physics Winner Integrator System 
and a Gilson 232-401 autosampler. Absorbance measurements were performed with a Pye 
Unicam model 8700 spectrophotometer.
2.3 Isoelectric focussing
The isoelectric points of the mabs were determined by isoelectric focussing using 
Ampholine PAG plates (pH range 3.5-9.5) according to the manufacturer's procedure.
2.4 Protein A Sepharose 4 fast flow Affinity Chromatography
A protein A Sepharose 4 fast flow column (0 10, h 13 mm) was equilibrated with 
binding buffer. The cell culture supernatant was diluted with an equal volume of binding 
buffer and filtered through a 0.2 ^m pore size membrane filter. Subsequently a volume 
containing a fixed amount of mab was loaded onto the column. The non-bound fraction was 
washed from the column with binding buffer. The fraction bound to the column was desorbed 
with 0.1 M citric acid (pH 5.0). During the whole process a linear flow rate of 76 cm/h was 
maintained. All fractions were immediately adjusted to neutral pH with 1.0 M tris/HCl 
(pH 9.0). After each run the column was regenerated by elution with three bed volumes of 
0.1 M citric acid (pH 3.0). The following parameters were monitored: absorbance at 280 nm, 
pH and conductivity. For longer periods of storage the column was stored at 4°C in 20% 
ethanol/water. In this study the dynamic binding capacity of protein A Sepharose 4 fast flow 
is defined as the amount of mab bound (mg) per volume of gel (ml) under the described 
operating conditions.
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2.5 Determ ination o f Protein Concentration
The total mouse IgG concentration in samples of hybridoma culture supernatants was 
determined using the sol particle immunoassay (SPIA) agglutination procedure as described 
by Leuvering10. The IgG concentration was calculated from a standard curve of each 
particular mab. The IgG concentration in the purified fractions was calculated from the 
absorbance at 280 nm using an extinction coefficient of 1.45 ml / (cm.mg).
2.6 Determ ination o f (Acid) P roteolytic A c tiv ity
Protease Substrate Gel Tablets containing agar and bovine casein were used for the 
determination of proteolytic activity. The manufacturer's procedure was followed with some 
modifications as described by van Erp et al.11. Proteolytic activity was calculated using a 
standard curve obtained with bovine cathepsin D.
2.7 High Performance Size Exclusion Chrom atography (HPSEC)
HPSEC analysis was performed on a Zorbax GF-250 column equilibrated with 0.2 M 
phosphate buffer (pH 7.0) at a flow rate of 1.0 ml/min. A sample of the IgG solution (20 ^l) 
was injected after prior 0.2 ^m pore size membrane filtration and detection was performed at 
206 nm. Purity was expressed as the percentage of monomeric IgG (peak area of 
monomeric IgG / total peak area corrected for salt peaks).
2.8 Calculation o f ion ic strength
Calculation of the ionic strength of the binding buffers (at 25°C) was performed 
according to the theory found in standard textbooks19. It was taken into account that all 
buffers, except the 0.1 M phosphate buffer, were adjusted to their final pH with 4 M NaOH or 
HCl solution. The composition of the binding buffers and their ionic strength are given in 
Table II.
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Table II Ionic Strength (mole / 1) of the Binding Buffers and their Effect on Binding Capacity 
(mg IgG /  ml gel) of Protein A Sepharose 4 fast flow for Mabs OT-hCG-1C and OT-hCG-4D
Binding buffer Ionic
Strength
Binding capacity 
Mab 1C Mab 4D
0.1 M sodium phosphate pH 8.1 0.3 0.5 0.7
0.1 M Na2B4O7, 0.15 M NaCl pH 8.5 --- 0.6 0.6
0.25 M glycine, 0.1 M tris, 0.1 M K2HPO4 pH 8.9 0.3 0.2 0.4
0.5 M glycine, 0.5 M NaCl pH 8.9 0.6 1.1 0.9
0.5 M glycine, 1.0 M NaCl pH 8.9 1.1 1.4 1.5
0.5 M glycine, 2.0 M NaCl pH 8.9 2.1 2.8 2.6
0.5 M glycine, 3.0 M NaCl pH 8.9 3.1 4.2 5.5
1.5 M glycine, 0.5 M NaCl pH 8.9 0.7 2.3 2.2
1.5 M glycine, 1.0 M NaCl pH 8.9 1.2 3.1 3.5
1.5 M glycine, 2.0 M NaCl pH 8.9 2.3 4.1 7.1
1.5 M glycine, 3.0 M NaCl pH 8.9 3.4 4.6 10.3
0.025 M glycine, 1.2 M K2HPO4 pH 9.0 3.6 8.7 20.7
0.025 M glycine, 1.2 M K2HPO4 pH 10.0 3.6 7.1 19.1
0.1 M tris, 1.0 M Na2SO4 pH 7.5 3.1 7.2 16.8
0.1 M tris, 1.5 M (NH4)2SO4 pH 7.5 4.5 8.9 19.6
Chromatographic conditions: column dimensions: 0 10, h 13 mm; flow rate: 76 cm / h; 
sample: 5 ml 2.0 mg / ml mab 1C and 2 ml 14.5 mg / ml mab 4D; ambient temperature.
3. RESULTS
Effects o f B ind ing  B u ffe r C om position
Affinity chromatographic purification of two mabs (OT-hCG-1C and 4D) was performed 
at ambient temperature, using thirteen adsorption conditions, differing in pH, concentration 
and type of ions (Table II). It was studied how these variations influence binding capacity of 
the protein A Sepharose 4 fast flow gel, binding of acid proteolytic enzymes and purity of the 
final IgG fraction based on HPSEC analysis.
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For the glycine/NaCl buffers it is essential that both compounds are present in high 
concentrations to obtain maximum binding capacity. Application of binding buffers with high 
concentrations of Na2SO4, (NH4)2SO4 or KH2PO4 resulted in a strong increase in binding 
capacity for both mabs as compared to the 1.5 M glycine 3 M NaCl buffer (pH 8.9).
The relative content of monomeric to aggregated IgG molecules in the desorbed 
fraction is affected by the type of buffer used during adsorption, as is shown by HPSEC 
analysis (Table III). In general, increasing the ionic strength of the binding buffer resulted in 
a higher monomeric IgG content and a lower content of IgG aggregates in the purified 
fraction.
- 27 -
Chapter 2
Table III Binding Buffers and their Effect on Purity, based on HPSEC Analysis, of the final IgG 
Fraction for Mabs OT-hCG-1C and OT-hCG-4D
Monomeric IgG* Aggregated IgG*
Binding buffer Mab OT-hCG: 1C 4D 1C 4D
0.1 M sodium phosphate pH 8.1 87.6 86.3 9.2 13.7
0.1 M Na2B4O7, 0.15 M NaCl pH 8.5 86.3 90.7 13.3 9.3
0.25 M glycine, 0.1 M tris, 0.1 M K2HPO4 pH 8.9 76.5 84.0 21.9 15.5
0.5 M glycine, 0.5 M NaCl pH 8.9 93.2 91.3 6.6 8.7
0.5 M glycine, 1.0 M NaCl pH 8.9 94.3 93.9 5.5 6.1
0.5 M glycine, 2.0 M NaCl pH 8.9 96.2 94.7 3.9 5.3
0.5 M glycine, 3.0 M NaCl pH 8.9 96.3 95.6 3.6 4.4
1.5 M glycine, 0.5 M NaCl pH 8.9 93.8 93.8 6.2 5.8
1.5 M glycine, 1.0 M NaCl pH 8.9 95.9 93.4 4.0 6.5
1.5 M glycine, 2.0 M NaCl pH 8.9 96.0 96.1 4.0 3.9
1.5 M glycine, 3.0 M NaCl pH 8.9 96.8 96.6 3.3. 3.3
0.025 M glycine, 1.2 M K2HPO4 pH 9.0 95.1 96.2 4.7 3.5
0.025 M glycine, 1.2 M K2HPO4 pH 10.0 95.1 96.2 4.6 2.9
0.1 M tris, 1.0 M Na2SO4 pH 7.5 96.1 94.9 3.9 5.1
0.1 M tris, 1.5 M (NH4)2SO4 pH 7.5 95.7 96.7 4.1 3.3
* % obtained by peak area/total peak area (corrected for salt peaks) x 100. 
HPSEC analysis: Zorbax GF-250 column, 0.2 M phosphate buffer (pH 7.0).
The conditions for protein A affinity chromatography were the same as in Table II.
The increase in binding capacity for the mabs is, however, also accompanied by an 
enhanced binding of acid proteases, as detected by tests on proteolytic activity (Table IV). 
The enzyme content was not sufficient to allow direct determination by methods like SDS- 
PAGE and HPSEC analysis.
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Effect o f Flow Rate on the B inding Capacity
The effect of flow rate during adsorption, varying from 9 to 300 cm/h was studied for 
mab OT-hCG-4D, using 1.5 M glycine 3.0 M NaCl (pH 8.9) as binding buffer. The flow rate 
during desorption of the bound fraction was kept constant at 76 cm/h. Only a minor effect of 
flow rate on the dynamic binding capacity was observed (Figure 1).
Table IV Effect of Binding Buffer on Proteolytic Activity in the Purified IgG Fraction
Binding buffer
Proteolytic activity (U / ml) 
OT-hCG-1C OT-hCG-4D
0.1 M sodium phosphate pH 8.1
*< <
0.5 M glycine, 0.5 M NaCl pH 8.9 < <
0.5 M glycine, 1.0 M NaCl pH 8.9 < <
0.5 M glycine, 2.0 M NaCl pH 8.9 < <
0.5 M glycine, 3.0 M NaCl pH 8.9 < <
1.5 M glycine, 0.5 M NaCl pH 8.9 < <
1.5 M glycine, 1.0 M NaCl pH 8.9 < <
1.5 M glycine, 2.0 M NaCl pH 8.9 < <
1.5 M glycine, 3.0 M NaCl pH 8.9 < <
0.025 M glycine, 1.2 M K2HPO4 pH 9.0 0.16 0.30
0.025 M glycine, 1.2 M K2HPO4 pH 10.0 0.15 0.20
0.1 M tris, 1.0 M Na2SO4 pH 7.5 0.10 0.50
0.1 M tris, 1.5 M (NH4)2SO4 pH 7.5 0.17 0.54
* Proteolytic activity is expressed as bovine cathepsin D activity;
< means below the detection limit: 0.05 U cathepsin D / ml.
The conditions for protein A affinity chromatography were the same as in Table II.
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Figure 1 Effect of flow rate during adsorption on the binding capacity of mab OT-hCG-4D to 
protein A Sepharose 4 fast flow. Chromatographic conditions: ambient temperature; column 
dimensions: 0  10, h 13 mm; adsorption: 1.5 M glycine 3.0 M NaCI (pH 8.9); desorption 0.1 M citrate 
(pH 5.0); sample 2  ml 14.5 mg /  ml mab 4D.
Effect o f Temperature on the B inding Capacity
The effect of temperature, 4°C versus ambient temperature (20-25°C), was studied for 
the mabs OT-hCG-1C, 4D, 3A, 6A and 7B and OT-HIV-4A and 4B, using 1.5 M glycine
3.0 M NaCl (pH 8.9) as binding buffer. If the chromatography was performed at 4°C, binding 
capacities for the investigated mabs varied from a 14% decrease to a 40% increase 
(Table V).
4. DISCUSSION AND CONCLUSION
From the results it is clear that the composition of the binding buffer with respect to 
ionic strength, pH and type of ion has not only an effect on the binding capacity of Protein A 
Sepharose 4 fast flow but also on the purity of the final IgG fraction.
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Table V Effect of Temperature on the Binding Capacity of Mabs of the IgG1 Subclass to Protein A 
Sepharose 4 fast flow
Binding capacity (mg IgG / ml gel)
Mab code mab applied (mg) 4°C AT difference(%)*
OT-hCG-1C 10.0 5.7 5.1 + 12
OT-hCG-4D 29.0 8.9 10.3 - 14
OT-hCG-3A 11.8 8.4 8.4 0
OT-hCG-6A 14.7 7.3 5.2 + 40
OT-hCG-7B 18.8 10.3 7.9 + 30
OT-HIV-4A 12.5 7.2 7.7 - 6
OT-HIV-4B 12.5 5.7 5.8 - 3
* difference in percentage with respect to binding capacity at ambient temperature (AT). 
Chromatographic conditions: column dimensions: 0  10, h 13 mm; flow rate 76 cm / h; 
adsorption: 1.5 M glycine 3.0 M NaCl (pH 8.9); desorption: 0.1 M citrate (pH 5.0).
Especially if the ionic strength is increased (Table II), the binding capacity of protein A 
Sepharose 4 fast flow can be improved with a factor of 20-30, depending on the particular 
mab and buffer, as compared to the frequently5,6,13 used 0.1 M phosphate buffer (pH 8.1). 
This implies that the number of moles mouse IgG1 bound per mole immobilized protein A 
increases from 0.03 to 0.94.
Under the operating conditions used a good comparison can be made of the effect of 
different adsorption buffers on the dynamic binding capacity of the protein A gel. 
Optimization with respect to binding efficiency was performed by adaptation of the column 
dimensions when the process was scaled up. Several large scale purifications were 
performed at ambient temperature, using a flow rate of 76 cm/h, 1.5 M glycine 3.0 M NaCl 
(pH 8.9) as binding buffer and columns with 0 16 or 26 mm and 100 mm bed height. 
Applying to these large scale columns an amount of mab equal to their binding capacities 
(see Table V), binding efficiencies of more than 95 % were obtained (results not shown).
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The effect of pH on binding13,15 can be explained by the role of both electrostatic and 
hydrophobic interactions at low ionic strength conditions. It is to be expected that at higher 
ionic strength conditions the hydrophobic interactions play a dominant role17. This is 
confirmed by the results obtained from this study with the 0.1 M tris 1.5 M (NH4)2SO4 and
0.1 M tris 1.0 M Na2SO4 buffers (pH 7.5), showing high dynamic binding capacities even at 
neutral pH. However besides the major role of ionic strength as shown by the sodium 
chloride series at two glycine concentrations also the chemical nature of the salt solutions 
affects the binding capacity. This is shown by the results: a) obtained for the 0.1 M tris 1.0 M 
Na2SO4 buffer (pH 7.5) which has equal or lower ionic strength than the two glycine buffers 
containing 3 M NaCl, and b) obtained for the 0.025 M glycine 1.2 M K2HPO4 buffer (pH 9.0) 
which has a little higher ionic strength than the 1.5 M glycine 3.0 M NaCl buffer but showed a 
factor of two higher binding capacity. This effect can be explained by the place of the ions in 
the Hofmeister (lyotrophic) series as reported by Melander14. This supplies more evidence 
that hydrophobic interactions play an important role in binding of (IgG1-) antibodies to 
protein A. Further confirmation is obtained from the results of Bywater1, who applied a 
variety of desorbing agents. From those experiments Bywater e t  a l .  concluded that the 
binding between protein A and IgG was dominated by interactions between aromatic 
residues, that is to say by a combination of hydrophobic interactions and electron 
donor-acceptor type interactions (n-rc). However the latter part of the conclusion seems 
doubtful because n-electron effects are antagonistic rather than collaborative in binding 
reactions, as can be concluded from data of Girifalco16.
Nustad et al.5 showed that the temperature had a negligible effect on the binding 
capacity for monoclonal antibodies of the subtypes IgG2a, IgG2b and IgG3. For the IgG1 
mabs however, he reported a five times higher binding capacity of protein A Sepharose for 
mouse monoclonal IgG1 antibodies at 4°C in comparison with 20-26°C, using a 0.1 M
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sodium phosphate binding buffer (pH 8.2). Furthermore, the binding capacity at room 
temperature was found to be fifteen times lower than for the other subtypes.
Results from the present study show that the temperature effect on the IgG1 binding 
capacity becomes of minor importance, if adsorption is performed in a high ionic strength 
(1.5 M glycine, 3.0 M NaCl) buffer pH 8.9. At these conditions mainly hydrophobic 
interactions play a role. The total interaction energy is then only sligthly affected by the 
temperature due to entropy changes being compensated for by enthalpy changes as 
described by Mukkur18.
The present results show that flow rates in the range of 10 - 300 cm/h only slightly 
affect the binding capacity, if a buffer with high ionic strength (1.5 M glycine, 3.0 M NaCl) 
and pH 8.9 is used. This can be explained by a strong increase of the functional binding 
activity of IgG and protein A, which is caused by promotion of the hydrophobic interactions 
according to the theory described above.
It appears that at relatively low ionic strength, binding of aggregated IgG molecules is 
preferred to binding of monomeric IgG molecules. Due to changes in conformation during or 
after the aggregation aggregated molecules become probably more hydrophobic than 
monomeric ones. As hydrophobic interactions play an important role, this may explain the 
higher functional binding activity of the aggregated IgG molecules. At high ionic strength 
conditions the hydrophobic parts of the monomeric IgG molecule become more expressed. 
This, together with the higher diffusitivity of these smaller molecules, may account for a 
higher functional binding activity for the monomeric molecules as compared to the 
aggregated molecules. The experimental results support this reasoning, as higher recovery 
of monomeric IgG was found, when applying high ionic strength conditions during binding. 
This is caused by preferential binding. Dissociation of aggregated IgG can be excluded,
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since HPSEC analysis revealed no change in the monomer/aggregate ratio, when the 
starting materials were diluted in binding buffer solution.
The major part of the proteolytic activity in both starting materials and the final IgG 
fractions was shown to be due to mouse cathepsin D12. Promotion of hydrophobic 
interactions also stimulates the binding of these acid proteases (Table IV). Although the 
relevance of this contamination of the IgG solution with acid proteases depends on the type 
of application the mab is intended for, it can considerably affect mab properties upon 
storage12. Whether or not degradation of the IgG molecule occurs, depends among other 
factors on pH and subclass of the mab. However, if required, the activity of cathepsin D can 
be inhibited by addition of pepstatin A.
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CHAPTER 3
Cross-contamination of monoclonal antibodies purified by means of 
protein A affinity chromatography
P. Machielsen, A. v. Sommeren and T. Gribnau 
Downstream, No 17. (1994) 25-27
Results about contamination of monoclonal antibodies (mcas), which are purified by 
means of protein A affinity chromatography, with bovine immunoglobulins (co-purification) 
and protein A (ligand leakage) have been published [1,2]. However, little or nothing has been 
published about cross-contamination of different mcas, which were purified on the same 
protein A column. A model study was performed to investigate to what extent this 
phenomenon occurs. To perform this study sandwich ELISAs were developed to determine 
low concentrations of a mca in solutions with relatively high concentrations of another mca.
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1. INTRODUCTION
Protein A affinity chromatography is a very popular method for purification of monoclonal 
antibodies because of its advantages (simplicity, speed and efficiency) above other 
techniques such as ion exchange chromatography, gel filtration and salt precipitation. 
A drawback of this technique, however, is the relatively high price of the protein A gel. For 
that reason, especially when different mcas are used for research purposes, purification is 
very often performed on the same column. This introduces the danger of contaminating one 
mca with one(s) purified earlier on the same column.
To determine at what level cross-contamination really occurs a model study was set up: 
three mouse IgG1 mcas, directed against different antigens, were purified on the same 
protein A column (applying frequently used chromatographic conditions [3]). First a mca 
directed against human Chorionic Gonadotrophin (hCG) was purified followed by a mca 
against a membrane protein of the rubella virus (Rub) and one against a component of the 
human immune deficiency virus (HIV). The anti-Rub mca was checked for traces of the mca 
directed against hCG and the anti-HIV mca for traces of both anti-hCG and anti-Rub using 
specific ELISAs.
The regeneration procedure of the protein A column, which is performed after each 
purification run, was also evaluated. After regeneration the column was equilibrated again in 
adsorption buffer and subsequently a mimic desorption step was performed. The amount of 
IgG in this desorption fraction, determined by means of an ELISA for mouse IgG, gives an 
indication about the necessity and efficiency of the regeneration procedure.
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2. EXPERIMENTAL
2.1 C ross-contam ination
2.1 .1  Chromatographic conditions
Column
Adsorption
Desorption
Neutralization
Regeneration
Detection
Equipment
: Protein A sepharose 4 fast flow (1.0 x 1.9 cm)
: 1.5 M glycine / 3 M NaCl pH 8.9, 75 cm/hr.
: 0.1 M citric acid pH 5.0, 37.5 cm/hr 
: 2 M tris/HCl pH 7.5
: 0.1 M citric acid pH 3.0, 37.5 cm/hr, 3 bed volumes 
: UV (280 nm), pH and conductivity
: FPLC-system with a UV-2 and an LKB 2195 pH/Ion monitor
After equilibration with adsorption buffer the column was loaded with IgG at 90% of its 
dynamic binding capacity. After desorption and neutralization the purified mcas were 
desalted using Sephadex G-25 PD 10 columns equilibrated in 9 g/l NaCl.
The purification experiments, using anti-hCG, anti-Rub and anti-HIV mcas, were performed 
in duplicate.
2 .1 .2  Cross-contamination/ELISA
Possible traces of a-hCG in the purified a-Rub mca were determined by means of ELISA: 
polystyrene microtitration strip-plates were coated with hCG, washed, dried and stored at 
4°C. A 100- m! volume of samples or standard was incubated for 1 h at 37°C. The wells were 
washed with 7 mM phosphate - 0.1 M sodium chloride containing 0.05% (w/v) of Tween 20 
(PBST) and incubated for 1 h at 37°C with 100 ^l per well of sheep (anti-mouse)IgG-HRP 
conjugate. The wells were washed again and incubated for 0.5 h at ambient temperature 
with 100 ^l per well of substrate (ureaperoxide) - chromogen (tetramethylbenzidine) solution.
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The reaction was stopped by addition of 1 M sulphuric acid (100 j l  per well). Absorbances at 
450 nm were determined using a microtitration plate reader. Concentrations of mca higher 
than 87 jg /m l for anti-Rub and 6 |jg/ml for anti-HIV caused a false positive response, which 
means that samples were diluted below these concentrations. The detection limit of the 
assay was 1 ng anti-hCG/ml.
For determination of anti-Rub mca in the purified anti-HIV mca the same test principle was 
used except that the strip-plates were coated with rubella antigen. A concentration above
12 jg /m l anti-HIV caused a false positive response. The detection limit of the assay was
4 ng anti-Rub/ml.
2 .1 .3  Results
Table 1 The amount of the concerning mcas was determined using specific ELISAs as described 
under experimental. Cross-contamination was expressed as (amount of contaminating mca /  amount of 
purified mca) x  1 0 0 %.
mca cross-contamination (%, w/w)
purified mca contaminating mca
a-hCG a-Rub
a-Rub 0.16
a-HIV
*
0.04
*The level of contaminating anti-hCG was below the detection limit of
the anti-hCG ELISA (1 ng / ml).
2.2 O ptim ization o f the regeneration procedure
Because cross-contamination was proved, investigations were performed with respect to 
improvement of the regeneration procedure. Therefore elution with additionally three bed 
volumes of 0.1 M citric acid pH 2 was performed as compared with the standard 
regeneration procedure (three bed volumes of 0.1 M citric acid pH 3). After regeneration the 
column was equilibrated again in adsorption buffer and subsequently a mimic desorption 
step was performed to determine if any mca was still eluted. This procedure was performed
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for three mcas, two of the IgG1 (anti-hCG and anti-Rub) and one of the IgG2a (anti­
Hepatitis B surface antigen (HBs)) subclass, using for each mca a new protein A column.
2.2 .1 ELISA
The mouse IgG content of samples taken during the regeneration, equilibration and 
mimicked desorption steps was determined as described in detail by Sommeren et al. [4]. 
In short: sample or standard was incubated in microtitration strip-plates coated with sheep 
anti-mouse IgG. The wells were washed, incubated with sheep anti-mouse IgG conjugated 
to HRP, washed again and incubated with substrate-chromogen solution. The reaction was 
stopped and the absorbances at 450 nm were determined. The detection limit of the assay 
was 1 ng/ml.
2 .2 .2  Results
The concentrations of anti-Rub IgG eluted in the regeneration and mimicked desorption 
fractions is visualized in the chromatogram and is shown in figure 1. Similar results 
(not shown) were obtained for the anti-HBs and anti-HIV mcas.
3. CONCLUSION
From the results it can be concluded that cross-contamination can occur when one column is 
used for purification of mcas by protein A affinity chromatography.
Modification of the regeneration procedure, using an additional elution with 0.1 M citric acid 
buffer pH 2 above the normally used elution with 0.1 M citric acid buffer pH 3 decreases the 
level of cross-contamination. However, as shown in figure 1 there was still IgG eluting during 
the mimicked desorption step.
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4. DISCUSSION
The level of cross-contamination (0.16 and 0.04% (w/w)) is comparable with the level of 
contamination with protein A (0.001-0.06% (w/w)) as described in the literature [1,2]. Possible 
effects of these levels of cross-contamination on mca performance is not yet clear and has 
to be considered for each particular application. It is even possible that it doesn't interfere at 
all. Polyclonal antibodies are often used as a total IgG fraction containing a bulk of 
non-specific IgG without causing problems in diagnostic tests and research applications. 
Further optimization of the regeneration procedure by evaluation of alternatives like 6 M 
Urea + 1 M acetic acid [5], 70% ethanol, or a combination of buffers with both changes in pH
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and in ionic strength could perhaps decrease cross-contamination below the current 
detection levels.
The easiest way however to prevent cross-contamination is to use one protein A column per 
mca as usually done for mcas to be used as therapeutic product.
Remark:
The results obtained in this study were confirmed by Hale et al [6]. Using hemagglutination 
assays with detection limits of 0.1 ^g/ml (rat) and 0.02 ^g/ml (human), they observed cross­
contamination of both rat IgG2b monoclonal antibodies by human IgG1 antibodies and vice 
versa at a level of around 0.01% (w/w). Moreover, they showed that cross-contamination can 
be reduced to an undetectable level - using the hemagglutination assays - by treatment of 
the protein A column with approximately 10 bed volumes of 0.5 M NaOH solution for 15 
minutes.
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Comparison of three activated agaroses for use in affinity chromatography: 
effects on coupling performance and ligand leakage
A.P.G. van Sommeren, P.A.G.M. Machielsen and T.C.J. Gribnau 
Journa l o f Chrom atography, Vol. 639 (1993) 23-31
ABSTRACT
Three commercially available activated supports, N-hydroxysuccinimide (NHS)-, tresyl 
chloride- and hydrazide-activated agarose, were compared with respect to coupling rate and 
coupling efficiency for the ligand and ligand leakage both during storage and 
chromatography. A monoclonal antibody against the E1 protein of the rubella virus was used 
as ligand. For each support the monoclonal antibody was immobilized at three 
concentrations: 0, and ca. 2.5, 5.0 and 10 mg IgG per ml gel.
The NHS-activated support showed very fast and complete binding of the ligand. Moreover, 
using this support ligand leakage was considerably less both during storage and during 
chromatography as compared to both others. It was also shown that the static binding 
capacity was comparable for the NHS- and tresyl chloride-derivatized agaroses and it was 
about a factor of two lower for the hydrazide-derivatized agarose.
© 1993 Elsevier Sience Publishers B.V.
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1. INTRODUCTION
Affinity chromatography based on antigen-antibody interactions, called 
immunosorption, is an extremely powerful technique and has been increasingly successful 
since the advent of mabs. When there is a suitable monoclonal antibody at hand 
immunosorption is an especially attractive technique for protein purification. Purification 
factors of 2 000 - 20 000-fold are often achievable, and it is sometimes possible to achieve 
purification to homogeneity in a single step.
The extensive use of antibody-containing affinity columns in the purification of 
biologically active compounds is severely hampered by the leaching of antibody or portions 
thereof from the immunoaffinity support during elution of the target antigen. Part of the 
problem is caused by the combined use of reducing agents (i.e. thiols) and chaotropic 
agents (e.g., detergents and denaturants) in the elution step, which causes the dissociation 
of heavy and / or light chains from the immobilized antibody. This part of the leakage 
problem can be diminished by, amongst other things, intramolecular cross-linking of the 
antibody chains at their sites of disulfide interlinkage using bifunctional SH-specific 
reagents [1] or via the lysine groups using glutaraldehyde. A decrease in the problems in this 
context can also be obtained by the selection of conjugation methods that yield a more 
stable chemical linkage between the matrix and the spacer and between the spacer and the 
antibody [2].
Many activated gel matrices ready for the reaction with a ligand are commercially 
available [3]. They differ in, amongst other things, the reactive group, the extent of activation, 
introduced spacer length and type, particle size and porosity. In practice, most of these gel 
matrices are based on beaded agarose.
In spite of some disadvantages activation by cyanogen bromide (CNBr) remains a popular 
method. The main disadvantages of CNBr-activated agarose stem from the isourea linkage 
[4] between the gel and the amino groups of lysine. The isourea derivative introduces an 
extra positive charge at neutral pH (pK ± 9.5), causing the gel to act as a weak ion
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exchanger at low salt concentrations. This does not usually present a problem. More serious 
is the fact that the isourea bond is reversible and can be cleaved e.g. by hydrolysis at weakly 
alkaline pH (>8) and by aminolysis with low-molecular-mass amines. In addition, very slow 
leakage of the (protein) ligand from the column occurs over a period of months to years [5].
Proteins may also be coupled to agarose which has been derivatized by spacer arms 
with N-hydroxysuccinimide ester at their ends [6]. Succinimide esters are very susceptible to 
nucleophilic attack by the e-amino groups of lysine, resulting in the formation of a stable 
amide bond between the protein and the spacer arm. Limitations of NHS esters in affinity 
chromatography and protein immobilization were described by Wilchek and Miron [2]. 
On reaction with ligands containing an amino group, the columns were unstable to alkali and 
were plagued by constant leakage during use. However they also described an alternative 
two-step method for the preparation of NHS esters, based first on the reaction of a carboxyl- 
containing matrix with a carbodiimide, that yield stable affinity columns.
Tresyl (trifluoromethyl sulphonyl) chloride-activated gel matrices are suitable for 
immobilization of amino- and thiol-containing ligands and allow efficient immobilization even 
at neutral pH. The ligand becomes immobilized to the matrix by stable -CH2-S- (thioether) 
or -CH2-NH- (amine) linkages. The thiol groups are more reactive than amines and also 
imidazole and tyrosine hydroxyl groups can displace the sulphonate ester [7].
A hydrazide matrix can be used for immobilization of ligands containing aldehyde and ketone 
groups [8]. The reaction occurs at low pH (about 5) and the chemical bond that is formed is a 
stable hydrazone, obviating the need for reduction (although this can be performed if 
desired) [9]. In the case of antibodies carbohydrate residues in the oligosaccharide chains, 
mainly at the Fc-part of the molecule, are oxidized at the vicinal hydroxyls to form aldehydes. 
This should have the advantage that antibodies are immobilized with optimum 
orientation [10].
The purpose of this investigation was to evaluate three commercially available 
products, hydrazide-, tresyl chloride- and NHS-activated agarose, with respect to their
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performance with regard to ligand leakage during storage and immunoaffinity 
chromatography. Moreover, the coupling speed and coupling efficiency for a mab, and the 
performance of the immunosorbents with respect to static binding capacities at three ligand 
densities were determined. These factors can be influenced by, amongst other things, 
temperature, pH, type and concentration of coupling buffer, use and type of spacer arm and 
nature of the ligand [7,11]. Because investigations according to these factors were beyond 
the scope of this work, preparation of the immunosorbents was performed to the 
manufacturer's protocol.
The purification of the E1-E2 glycoprotein complex (Mr 300 000) of the rubella virus 
from culture fluid was used as a model for this study. A mab directed against the E1 protein 
of the antigen complex was immobilized on the three gels at three different concentrations. 
It has been reported that rubella virus proteins are unstable at low pH [12] and that they can 
be purified by immunochromatography using 0.5 M diethanolamine pH 11.5 [13]. Also in this 
investigation alkaline conditions were used to elute the bound antigen from the column. 
Because the isourea bond is not stable under these conditions, CNBr-activated agarose was 
excluded from this evaluation.
2. EXPERIMENTAL
2.1 Materials and reagents
Tresyl-activated Sepharose 4 fast flow (FF) and protein A Sepharose 4 FF were 
purchased, and NHS-activated Sepharose 4 FF (a prototype gel containing 22 ^mol of 
NHS-groups per ml gel stored in isopropanol) was obtained as a gift from Pharmacia 
(Woerden, The Netherlands). Affi-Gel Hz was purchased as a complete kit from Biorad 
(Veenendaal, The Netherlands). A Micro BCA protein assay kit was purchased from Pierce 
(Oud-Beijerland, The Netherlands). A Glycan Detection Kit was purchased from Boehringer 
(Mannheim, Germany). All other chemicals were of analytical-reagent grade.
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The liquid chromatographic system was supplied by Pharmacia and consisted of two 
P-500 piston pumps, an MV-7 valve, a UV-M II monitor, a FRAC-200 fraction collector and a 
flat-bed recorder. A microwell system (model 510 reader, model 500 incubator and model 
500 washer) was obtained from Organon Teknika (Turnhout, Belgium).
2.2 Protein purifica tion
Monoclonal antibodies. Mab OT-Ru-5, 27 and 28, all specific for the E1 protein of the 
rubella virus, were produced under protein free conditions in a hollow-fiber dialysis system 
[14,15] and were purified by means of protein A affinity chromatography [16].
Antigen. Rubella virus was produced in Baby Hamster Kidney (BHK) cells persistently 
infected with the vaccine strain HPV-77. The protein fraction was extracted with Tween- 
diethylether and concentrated 20-fold by ultra-filtration using a 100 kDa filter. 
Phenylmethylsuphonyl fluoride (PMSF), sodium azide and cinnamaldehyde were added to 
the antigen solution at concentrations of 2 mM, 3 mM and 5 mM, respectively. The pH was 
adjusted to 7.3 using 1.0 M Na/K phosphate buffer pH 6.5. The solution was centrifuged for
15 min at 4 000 g and the supernatant was filtered through a 0.45 ^m pore size filter.
It should be noted that the amount of active protein was only 0.02% w/w of the total amount 
of protein in the starting material.
2.3 Preparation o f the im m unosorbents.
Mab OT-Ru-28 was coupled to the activated supports according to the manufacturers 
protocol. A schematic illustration of the bonds formed between the activated supports and 
the mab is given in Fig. 3
Hydrazide-activated support. The solvent, in which the mab was dissolved, was 
exchanged for coupling buffer pH 5.5 using an Econo-Pac 10 DG column. The column and 
buffer were included in the Affi-Gel Hz kit. Oxidation of IgG carbohydrates was performed by
- 50 -
Comparison of activated agaroses for use in affinity chromatography
adding 10 v/v % of 0.1 M NaIO4 in water to the mab solution. This mixture was incubated 
for 1 h by end-over-end rotation in the dark at ambient temperature. The solvent was 
exchanged for coupling buffer by means of gel filtration using an Econo-Pac 10 DG column. 
The final IgG concentration was determined by UV measurement at 280 nm using an 
extinction coefficient of 1.45 ml / (cm.mg).
A portion of 6 ml of gel in isopropanol was washed twice with 12 ml of coupling buffer. 
Mab in coupling buffer was added in amounts of 0, 3.4, 7.4 and 14.8 mg to portions of 1.5 ml 
of gel. The volume of the incubation mixtures was adjusted to ca. 6 ml by adding coupling 
buffer. Incubation was performed by end-over-end rotation for 24 h at ambient temperature. 
After incubation for 2, 4 and 24 h samples were taken from the supernatant to determine the 
coupling performance. To remove non-covalently bound antibody [17] the gels were washed 
on a sintered glass filter with ca. 25 bed volumes of 7 mM phosphate + 0.1 M NaCl pH 7.3 
(PBS), PBS + 1 M NaCl, cold water, 0.1 M Na2CO3 + 0.5 M NaCl pH 11, 0.1 M sodium 
acetate + 0.5 M NaCl pH 4, 0.1 M Na2CO3 + 0.5 M NaCl pH 11, 0.1 M sodium acetate + 
0.5 M NaCl pH 4 and again PBS. The gels were stored at 4°C in PBS containing 3 mM 
sodium azide.
Before each incubation with antigen solution, the gels were washed with approximately 
four bed volumes of 10 mM Na2CO3 pH 11 and PBS.
Tresyl-activated support. Lyophilized tresyl-activated Sepharose (1.8 g) was swollen 
for 1 h in 1 mM HCl. The swollen gel was washed on a sintered-glass filter successively with 
360 ml of 1 mM HCl and 150 ml of 9 g/l NaCl. The gel was suspended in an equal volume of 
0.1 M NaHCO3/0.5 M NaCl pH 8.3 (coupling buffer). To 3 ml portions of this gel suspension 
mab in coupling buffer was added in amounts of 0, 4.2, 8.4 and 16.8 mg. The volume of the 
incubation mixtures was adjusted to approximately 6 ml with coupling buffer. Incubation was 
performed by end-over-end rotation for 24 h at ambient temperature. During and at the end 
of incubation samples were taken from the supernatant to determine the coupling 
performance. After coupling the supernatant was removed, 3 ml of 0.1 M tris/HCl pH 8.0 was
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added to the gels and incubation was continued for 4 h at ambient temperature. The gels 
were washed, stored and equilibrated as described for the hydrazide-activated support.
NHS-activated support. Approximately 12 ml of a 66% v/v slurry was washed on a 
sintered glass filter with 120 ml of 1 mM HCl at 4°C. The gel was suspended with an equal 
volume of 0.2 M NaHCO3/0.5 M NaCl pH 8.2 (coupling buffer). Immediately afterwards, mab 
in coupling buffer was added in amounts of 0, 4.3, 8.6 and 17.2 mg to 3-ml portions of gel 
suspension. The volume of the incubation mixtures was adjusted to ca. 6 ml with coupling 
buffer. Incubation was performed by end-over-end rotation during 5 h at ambient 
temperature. During and at the end of incubation samples were taken from the supernatant 
to determine the coupling performance. Although not prescribed, the gels were incubated 
with 3 ml of tris/HCl pH 8.0 for 17 hours at 4°C. The gels were washed, stored and 
equilibrated as described for the hydrazide activated support.
2.4 Determ ination o f s ta tic  b ind ing capacity and b inding effic iency.
The static binding capacity was measured in batch experiments, for which it was 
determined that 16-20 h of incubation was ample time for equilibrium to be established. 
Six different amounts of antigen were incubated with 40 |jl of a 25% v/v gel suspension of 
each immunosorbent. Incubation was performed by end-over-end rotation for 16-20 h at 
ambient temperature. After settling of the gel, the amount of antigen in the supernatant was 
determined by means of an enzyme-linked immunosorbent assay (ELISA).
2.5 Determ ination o f ligand leakage
In the supernatants obtained during a period of up to three months after preparation of 
the gels and storage at 4°C and in preparations obtained during purification, the IgG content 
was determined by means of ELISA.
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2.6 Chrom atography
Purification was performed with the immunosorbents containing 3.0, 2.6 and 2.9 mg of 
IgG/ml gel based on the hydrazide-, tresyl- and NHS-activated supports, respectively. 
Portions of 1 ml of a 25% v/v gel suspension (duplicates) were incubated with antigen 
solution (1 000 U/ml gel). Incubation was performed batchwise by end-over-end rotation for 
16-20 h at ambient temperature. After incubation the gel was transferred to a C10/10 column 
(Pharmacia) and washed with PBS (75 cm/hour) until the original baseline (absorbance 
at 280 nm) was reached. The adsorbed antigen was eluted with 10 mM Na2CO3 pH 11 
(15 cm/hour). The pH of the eluted antigen fraction was neutralized with 1 M 
4-(2-hydroxyethyl)-1-piperazine-ethane-sulphonic acid (hepes) pH 6.5.
2.7 Determ ination o f Rubella E l-an tigen  activ ity  using ELISA
Polystyrene microtitration stripplates were coated overnight at ambient temperature 
with a 2.5 |jg/ml solution of mab OT-Ru-5. The plates were washed with PBS containing
0.05% w/v of Tween 20 (PBST), dried and stored at 4°C. Samples and standards were 
diluted with PBST and incubated (100 j l  per well) for 1 hour at 37°C. The wells were washed 
with PBST (300 j l  per well) and incubated with 100 j l  of conjugate solution (HRP conjugated 
to mab OT-Ru-27) in PBST for 1 hour at 37°C. The wells were washed again and incubated 
for 0.5 h at ambient temperature with (100 j l  per well) substrate (ureaperoxide)/chromogen 
(Tetra Methyl Benzidine) solution. The reaction was stopped by addition of 1 M sulphuric 
acid solution (100 j l  per well). Absorbances at 450 nm were determined using a 
microtitration plate reader. The measuring range of the assay was: 0.025 - 0.1 U antigen/ml. 
Units are obtained by defining an in-house rubella antigen solution arbitrarily as 10 U/ml.
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2.8 Determ ination o f mouse IgG using ELISA
Polystyrene microtitration strip-plates were coated with sheep anti-mouse IgG at a 
concentration of 0.7 jg /m l in 50 mM sodium carbonate buffer pH 9.6 at ambient temperature 
for 24 hours. The coated plates were washed, dried and stored at 4°C. A 100-jl volume of 
diluted sample or standard (mab OT-Ru-28) was pipetted into each well and incubated 
for 1 hour at 37°C. The wells were washed and incubated with sheep anti-mouse IgG 
conjugated with HRP for 30 minutes at 37°C. The wells were washed again and incubated 
for 0.5 h at ambient temperature with 100 j l  per well of substrate/chromogen solution. 
The reaction was stopped by addition of 1 M sulphuric acid (100 j l  per well). Absorbances 
at 450 nm were determined using a microplate reader. The measuring range of the assay 
was 1 - 10 ng IgG/ml.
2.9 Determ ination o f prote in content
Samples and standard [bovine serum albumin (BSA)] solutions were diluted in 0.15 M 
NaCl and 100 j l  were pipetted into the well of a microtitration strip-plate. A 100-jl volume of 
Micro BCA working reagent was added per well and the plate was incubated for 1 hour 
at 50°C. Absorbances at 540 nm were determined using a microplate reader. The measuring 
range of the assay was 1 - 20 jg /m l.
3. RESULTS AND DISCUSSION
3.1 Determ ination o f coup ling  perform ance
The amount of mab OT-Ru-28 IgG in the samples taken during and at the end of the 
coupling and taken during the wash cycles (see preparation of the immunosorbents) was 
determined by means of ELISA. It was confirmed that periodate oxidation of the mab had no 
effect on the reactivity in the ELISA for mouse IgG. The ligand density, defined as mg of IgG 
coupled per ml of gel, and the coupling efficiency, defined as (amount of IgG
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coupled / amount of IgG offered) x 100%, were calculated and are given in Table I. 
The amount of IgG coupled was calculated by subtracting the total amount of IgG found in 
the supernatant after coupling and in all wash fractions from the amount of IgG offered.
For hydrazide- and tresyl-activated supports coupling efficiencies based on the ELISA 
results were confirmed by measurements of the absorbance at 280 nm (A280) of the 
supernatant (results not shown). Because of the high A280 of NHS, which is released during 
coupling, supernatants obtained after coupling were analysed for IgG content using HPSEC 
(Zorbax GF-250 column, 20 ^l injection volume, 0.2 M phosphate buffer pH 7.0 and 
detection at 206 nm). No IgG could be detected, which confirmed the results obtained from 
the ELISA.
Table I LIGAND DENSITY AND COUPLING EFFICIENCY
Immobilization of mab OT-Ru-28 to hydrazide-, tresyl-, and NHS-activated agarose matrices was 
performed by overnight coupling at ambient temperature, followed by an extensive washing procedure 
as described in detail under Experimental. The amount of uncoupled mab was determined using ELISA 
for mouse IgG and used to calculate coupling efficiency and ligand density.
Immunosorbent ligand density 
(mg IgG / ml gel)
coupling efficiency 
(%)
Hydrazide 0 0
1.3 54
3.0 60
7.8 79
Tresyl 0 0
2.6 93
5.3 96
8.9 81
NHS 0 0
2.9 100
5.4 100
11.1 100
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Time (h)
Figure 1 Determination of coupling rate and coupling efficiency of mab OT-Ru-28 to NHS-activated 
agarose offering 2.9, 5.4 or 11.1 mg /  ml gel [all the same curve (■)], hydrazide-activated agarose 
offering (▲) 2.3 or (X) 9.9 mg /  ml and tresyl-activated agarose offering (*) 2.8 or (+) 11.2 mg /  ml.
Washing the gel directly after coupling to remove non-covalently bound IgG resulted 
with the tresyl- and hydrazide-activated agarose only in a minimal loss of ligand compared 
with the amount of IgG coupled. No IgG could be detected in the wash fractions of the NHS- 
activated gels.
The coupling of mab OT-Ru-28 to NHS-activated agarose is completed within 30 
minutes for all three concentrations tested (Fig. 1). This fast and efficient coupling of mab 
agreed very well with the results obtained by Matson and Little [18].
After incubation for 4-5 h, coupling of mab to the hydrazide- and tresyl choride-activated 
supports is almost at its maximum (81-96%); longer incubation times result only in a slightly 
higher ligand density. These results were also in good agreement with those reported [7,19].
A relatively low binding efficiency of 54-79% after incubation for 24 h was observed for 
the hydrazide-activated support. This may be due to the degree and type of glycosylation of
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Table II LIGAND LEAKAGE DURING STORAGE
IgG leakage was determined by ELISA for mouse IgG on the supernatants of the immunosorbents 
after a storage period of 3 months in 7 mM phosphate + 0.1 M NaCl pH 7.3 + 0.02% NaN3  at 4°C.
Immunosorbent Ligand density 
(mg IgG / ml gel)
Ligand leakage 
(pg IgG / ml gel)
Hydrazide 1.3 11
3.0 21
7.8 31
Tresyl 2.6 15
5.3 104
8.9 >120
NHS 2.9 0.008
5.4 0.028
11.1 0.291
Table III DETERMINATION OF BINDING CAPACITY 
Binding capacities of the immunosorbents were determined using 
ambient temperature) with antigen. The amount of unbound antigen 
binding capacity was defined as the amount of antigen (U) bound 
efficiency of 80%.
batchwise incubation (16-20 h, 
was determined by ELISA. The 
per ml immunosorbent with an
Gel Ligand density Bind. capacity
(mg IgG / ml) (U / ml gel)
Hydrazide 1.3 325
3.0 500
7.8 555
Tresyl 2.6 1130
5.3 1115
8.9 1235
NHS 2.9 1060
5.4 1083
11.1 1080
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Ag offer (U)
Figure 2 Determination of the binding efficiency of the immunosorbents based on (■) NHS- 
activated agarose, (+) hydrazide-activated agarose and (▲) tresyl-activated agarose with ligand 
densities of 2.9, 3.0 and 2.6 mg mab /  ml gel, respectively.
the antibody molecule, causing a limited amount of aldehyde groups on the oxidized 
antibody, or to sub-optimum coupling conditions for this particular mab.
3.2 Determ ination o f ligand leakage during storage
The leakage of ligand from the gel during storage is the strongest for the tresyl- 
activated gel followed by the hydrazide matrix. Detailed results are given in Table II. 
With the NHS-activated gel almost no IgG could be detected in the supernatants.
3.3 Static b ind ing capacity
The static binding capacities of the immunosorbents are summarized in Table III, and 
were determined as described in Experimental. They were read from the binding efficiency 
curve at the 80% point. This definition gives a practically useful binding capacity and is not 
the maximum binding capacity of the immunosorbent. The binding efficiency curves for the 
three gels which were formerly used in purification experiments are shown in Fig. 2.
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No binding was observed when the antigen was incubated with the gels containing no 
ligand which excludes non-specific adsorption.
Static binding capacities for immunosorbents based on the tresyl- and NHS-activated 
gels were about equal and increasing the ligand density from 2.6 to 11.1 mg IgG/ml did not 
result in an increase in static binding capacity. Instead of an improved binding capacity as 
expected by oriented coupling of the mab molecules, immunosorbents based on the 
hydrazide-activated gels had binding capacities that were only half or less than that of the 
other two supports.
Orthner et al. [20] found that their mabs against human plasma proteins factor IX or 
Protein C also contained carbohydrates in the Fab' region. Carbohydrate analysis of intact 
IgG and F(ab')2 fragments of Mab OT-Ru-28B under reducing and non-reducing conditions 
showed that sugars were only present on the Fc-part. This excluded coupling via the antigen 
binding site.
Whether the reduced activity is due to the oxidation step was not investigated. Orthner 
et al. [20] found for their mabs no reduced activity caused by oxidation. However Fleminger 
et al. [21] showed for several mabs a loss of activity up to 26% after incubation with 10 mM 
sodium periodate for 1 h in the dark at 4°C. They also showed that increasing the 
temperature during the oxidation step to ambient temperature resulted in a rapid inactivation 
of the more sensitive antibodies. Another reason for the reduced activity may be that sodium 
periodate oxidizes not only the carbohydrate moieties, but also certain amino acid residues, 
particularly N-terminal serine, threonine and methionine. Whenever these residues are 
essential for the antigen binding activity of an antibody, their oxidation may harm its activity.
Because the immunosorbents were useful for isolation of rubella virus proteins and 
optimization of the binding capacity, which was outside the scope of this investigation, has 
been thoroughly discussed in the literature [22, 23], no further attention was devoted to this 
subject.
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Table IV LIGAND LEAKAGE DURING CHROMATOGRAPHY
The amount of mouse IgG was determined using ELISA and the amount of total protein was 
determined using the Micro BCA protein assay. For details, see Experimental. Contamination of the 
purified antigen fraction with anti-rubella mab was determined in duplicate. Contamination was 
expressed as (amount of mouse IgG /  amount of total protein) x  100%.
Immunosorbent
Ligand density 
(mg IgG / ml gel)
Contamination (% w/w) 
run 1 run 2
Hydrazide 3.0 0.44 0.50
Tresyl 2.6 0.26 0.33
NHS 2.9 0.02 0.02
3.4 Determ ination o f ligand leakage during chrom atography
Ligand leakage during chromatography using an immunosorbent based on NHS- 
activated agarose is about a factor of fifteen lower than that using the sorbent prepared from 
tresyl-activated agarose and more than a factor of twenty lower than that using the sorbent 
based on hydrazide-activated agarose (see Table IV). This means that instability towards 
alkali of ligands coupled to a NHS-group containing support, as been noted by Cuatrecasas 
and Parikh [6] and Wilcheck and Miron [2], is almost overcome.
Because the amine linkage formed after reaction of tresyl with amino-groups is a 
stable bond, the higher ligand leakage for the tresyl-activated agarose in comparison with 
the NHS-activated gel can be explained by the lower stability at high pH of the bonds 
probably formed by side-reactions with imidazole or tyrosine hydroxyl groups. As IgG has no 
free thiol groups, the presence of a thioether bond is not likely.
The relatively high contamination of the final product with mouse IgG (expressed 
as % w/w) observed for the hydrazide gel can partly be explained by the lower binding 
capacity of this immunosorbent. Other explanations may be the lower stability of the 
hydrazone bond at high pH as compared with the amine and amide bonds (see Fig. 3), 
or that leakage is related to the way of introduction of the hydrazide group into the support.
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OH OH O [A]
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- O - C H 2 - C H - C H 2 - O - C H 2 - C H - C H 2 - N H - C H 2 - C H 2 - C H 2 - C H 2 - C H 2 - C - N H - m a b
■  - C H 2 - N H - m a b  [B] ■■   M - C H 2 - S - m a b  [C]
O■
support:
C - N H - N = C H - m a b  [D]
■
Figure 3 Immobilization of an amino-containing ligand (mab-NH2) to the [A] NHS- and [B] tresyl- 
activated support. Coupling of a thiol-containing ligand (mab-SH) to the [C] tresyl-activated support and 
coupling of an aldehyde-containing ligand (mab-CHO) to the [D] hydrazide-activated support.
4. CONCLUSION
It was concluded that of the three activated supports evaluated, NHS-activated 
Sepharose 4 fast flow is the most suitable activated matrix with respect to (mab) ligand 
leakage both during storage at neutral pH and during chromatography using alkaline 
(pH 11.0) desorption conditions. Improvement of ligand leakage for this gel in comparison 
with earlier available NHS-activated agaroses was obtained by introducing the spacer arm 
via epoxy activation to the polysaccharide matrix [24], which results in a stable ether bond, 
followed by a suitable method for introduction of the NHS ester. For the mab used in this 
investigation it was shown that the desired ligand density can be exactly achieved because 
coupling is complete within 30 min of incubation.
Two minor practical disadvantages of this gel are that the succinimide ester gives 
COOH-groups after hydrolysis, which introduce an extra charge, causing the gel to act as an 
ion exchanger at low salt concentrations, and that the progress and efficiency of coupling of 
protein cannot be followed by simple ultraviolet absorption measurement because NHS also 
absorbs strongly.
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Purification of rubella virus E1-E2 protein complexes by 
immunoaffinity chromatography
A.P.G. van Sommeren, P.A.G.M. Machielsen, W.J.G. Schielen, H.P.J. B loemers and 
T.C.J. Gribnau 
Journa l o f V iro log ica l Methods, Vol. 63 (1997) 37-46 
ABSTRACT
A murine monoclonal antibody directed against the E1 membrane glycoprotein of 
rubella virus was immobilized on an N-hydroxysuccinimide-activated chromatographic 
support. The antibody was used to purify rubella virus E1-E2 protein complexes from 
Tween-80 / diethyl ether extracts of cell culture supernatants containing virus particles.
The adsorption behaviour of immunosorbents with ligand densities of 2.9, 5.4 and 11.1 mg 
monoclonal antibody per millilitre of gel was investigated using batchwise conditions. Then 
the immunoaffinity purification process was optimized with regard to adsorption efficiency by 
adjusting the flow rate, the bed height and the amount of sample loaded onto the column.
The optimized immunoaffinity purification process which is reproducible and relatively simple 
(one-step) had a yield of 73%, a concentration factor of 5 - 8 and a purification factor of 
about 2 600. No mouse IgG due to ligand leakage could be detected in the immunopurified 
product using an enzyme immunoassay. High-performance size exclusion chromatography, 
sodium dodecyl sulphate polyacrylamide gel electrophoresis, immunoblotting and electron 
microscopy showed that the immunopurified product contained rosette-like structures formed 
by complexes of E1 and E2 proteins. The product retained its hemagglutinating activity and 
proved to be suitable for application in a fluorescent enzyme immunoassay for determination 
of anti-rubella IgG in human serum.
Key-words: Rubella virus, Hemagglutinin, Immunoaffinity, Purification, Immunoassay, 
Viral envelope proteins
© 1996 Elsevier Science B.V.
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1. INTRODUCTION
Rubella virus (RV) is the sole member of the genus Rubivirus of the family Togaviridae 
(Murphy, 1996). Rubella is a very widespread disease which usually causes only mild 
symptoms. However, it is of clinical significance due to its capacity to induce congenital 
malformation and persistent infection in the human fetus if the infection occurs during 
pregnancy, especially in the first trimester (Gregg, 1941; Munro et al., 1987 and Wolinsky, 
1990). Therefore, the screening of pregnant women for antibodies to RV in order to detect 
immunity or susceptibility is a major factor in the prevention of such abnormalities. 
The presence of these antibodies is most frequently determined by means of enzyme-linked 
immunosorbent assays (ELISA) or other immunoassay methods using whole virus or viral 
extracts.
The structure and genome organization of RV is similar to that of the alphaviruses 
(Dominquez et al., 1990). The genomic RNA is enclosed in an icosahedral nucleocapsid 
composed of multiple copies of a single protein, the non-glycosylated capsid or C protein 
(Mr 34 kDa) (Ho-Terry and Cohen, 1982; Waxham and Wolinsky, 1983; Oker-Blom et al., 
1983). The nucleocapsid is surrounded by a lipid bilayer envelope which the two virus- 
specific glycoproteins E1 and E2 (Mr's 58 kDa and 42-47 kDa, respectively) are embedded 
in.
The purpose of this investigation was to develop a reproducible and rapid purification 
procedure for the diagnostically relevant E1 and E2 glycoproteins. These proteins had to be 
immobilized on a solid phase suitable for application in a diagnostic enzyme immunoassay.
Purification of the E1 and E2 glycoproteins is difficult for several reasons: RV does not 
grow to high titers in cell cultures (Best et al., 1992), and the solubility of the glycoproteins 
which project from the virion as 6 - 8 nm surface spikes is limited (Wolinsky, 1990). 
Moreover, it has been reported that rubella E1 fusion proteins, virions and hemagglutinin 
(HA) extracts are inactivated quickly under acid conditions (Chagnon and Laflamme, 1980; 
Terry et al., 1989).
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Several procedures for the isolation of rubella viral particles or hemagglutinin 
(Vaananen and Vaheri, 1971; Vaheri and Hovi, 1972; Trudel et al., 1981; Zhang et al., 1992) 
and for the purification of the structural proteins (Schmidt et al., 1966; Kalkkinen et al., 1984) 
have been described. Chong and Gillam (1985) described a procedure based on monoclonal 
antibody immunoaffinity chromatography, intended, however, for analytical purposes rather 
than purification on a preparative scale. They bound the virus particles to the monoclonal 
antibody column and disrupted the virus with buffers containing a detergent. Finally, they 
chose 5% diethanolamine (pH 11.5) for desorption, because it yielded 100% recovery of 
bound 35S-labeled components and 65% recovery of hemagglutination activity. 
Furthermore, they showed that the purified material contained all three structural 
polypeptides of RV.
The results of a new method for the isolation of hemagglutinins from viral cell culture 
supernatants, are described. The method includes Tween-80 and diethyl ether extraction, 
subsequent ultra-filtration and, finally, a one-step immunoaffinity purification procedure using 
a monoclonal antibody against rubella E1 protein immobilized on N-hydroxysuccinimide- 
(NHS)-activated Sepharose 4 fast flow (FF). Based on our experience with other 
immunopurification procedures, 0.01 M sodium carbonate buffer (pH 11.0) was used for 
elution of the bound fraction.
2. EXPERIMENTAL
2.1 B iochem icals
RV was cultured in baby hamster kidney (BHK) cells infected persistently with the 
vaccine strain HPV-77. The method used for inactivation of viral activity was treatment with 
B-propiolacton: 25 ml of a 0.9 M NaHCO3 solution and 10 ml of a 10% (v/v) B-propiolacton
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solution were added to 1 l of cell culture supernatant and incubated for 4 days at 4°C under 
a continuous nitrogen flow.
Extraction of the extracellular viral protein fraction was performed using Tween-80 and 
diethyl ether [Hemagglutinin (HA)]. Subsequently, the protein fraction was concentrated 
20-fold by Pellicon tangential flow ultra-filtration using an Mr 100 000 filter (Millipore, 
The Netherlands) and stored at -20°C. A mock-infected cell culture supernatant was 
produced under the same conditions.
Monoclonal antibodies (Mab) RU.OT5C, RU.OT28B and RU.OT27B, each specific for 
the E1-protein of RV, were produced under protein-free conditions in a hollow fiber dialysis 
system (Schonherr et al., 1987). The properties of the Mabs with respect to epitope 
specificity, hemagglutination inhibition activity and neutralizing activity have been described 
by Ho-Terry et al., 1986. Purification was performed by means of protein A affinity 
chromatography (van Sommeren et al., 1992). Rabbit anti-capsid serum was produced in­
house. The ascites fluid of the Mab against the E2-protein was obtained from J.S. Wolinsky 
(University of Texas, Houston, USA).
The Rubenosticon reagents used have been manufactured by Organon Teknika, 
Belgium. The Rubazyme IgG EIA has been obtained from Abbott Laboratories, 
The Netherlands. The prestained standard mixtures of molecular weight calibration proteins 
for SDS-PAGE and western blotting have been obtained from BRL, The Netherlands.
2.2 Chrom atography equipm ent
The HPLC system consisted of a Pharmacia/LKB pump 2150, controller 2152, variable 
wavelength detector 2151, a Superrac fraction collector, a Gilson autosampler 232, 
a Spectra Physics Integrator SP4270 and "Winner" software. The Pharmacia (FP)LC system 
consisted of a UV-2 detector, P-1 and P-500 Pumps, a Frac-200 fraction collector, a V-7 
valve and a model 2195 pH/Ion monitor.
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2.3 ELISA fo r determ ination o f rubella E-1 antigen activ ity
The amount of E1-activity in starting materials and the purified fractions was 
determined by using a sandwich-type ELISA. Mab RU.OT5C and Mab RU.OT27 were used 
for immobilization on the solid phase and for preparation of a horse radish peroxidase 
conjugate, respectively. The procedure has been described in detail by van Sommeren et al. 
(1993). The measuring range of the assay was 0.025 - 0.1 U of antigen / ml, based on an 
in-house rubella antigen solution defined arbitrarily to contain 10 U / ml.
2.4 ELISA fo r determ ination o f mouse IgG
The amount of mouse IgG in the purified fractions was determined by using a 
sandwich-type ELISA (van Sommeren et al., 1993). The measuring range of the assay was 
1 - 10 ng IgG / ml, based on Mab RU.OT28B as a standard.
2.5 Determ ination o f the hem agglutination activ ity
Rubenosticon reagents were used to perform a direct hemagglutination assay to 
determine the viral hemagglutination activity of the rubella antigen preparations. A dilution 
series of the samples was prepared using Rubenosticon diluent. 100 j l  of each dilution were 
pipetted into the wells of a microtitration plate. Subsequently, 100 |jl of diluent and 100 j l  of 
a 5% sheep erythrocyte suspension in diluent were added to each well. After 5 h of 
incubation at ambient temperature, the sedimentation patterns were read and the results 
were expressed as hemagglutination titers.
2.6 Determ ination o f prote in content
Protein concentrations were determined using the micro bicinchoninic acid (BCA) 
method (Pierce, Rockford, IL USA). Samples and standard [bovine serum albumin (BSA)] 
solutions were diluted using 0.15 M NaCl. 100 j l  of each solution were pipetted into the wells
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of a microtitration stripplate. 100 j l  of micro BCA working reagent were added to each well. 
The plate was incubated for 1 h at 50°C. Absorbances at 540 nm were determined using a 
microplate reader. The measuring range of the assay was 1 - 20 jg/m l.
2.7 Sodium dodecyl sulphate polyacrylam ide gel e lectrophoresis
Two parts of the purified rubella antigen fractions were mixed with one part of sample 
buffer containing 6% SDS, 30% glycerol, 0.05% bromophenol blue and 0.2 M tris buffer 
(pH 6.8, with 15% 2-mercaptoethanol as a reducing agent). The fractions were boiled 
for 4 min and then subjected to electrophoresis for 45 min at a constant voltage of 
200 V in homogeneous polyacrylamide gels (8.5% T = total acrylamide concentration and 
2.6% C = cross-linker concentration expressed as a percentage of the total acrylamide) 
using the Mini Protean II system (BioRad, The Netherlands). Finally, silver staining was used 
to make the proteins visible in the gel.
2.8 W estern im m unob lo t analysis
Proteins in SDS-PAGE gels were transferred electrophoretically to a nitrocellulose 
membrane (Towbin et al., 1979) using the Mini Protean II blotting system for 1 h at 150 mA. 
The membrane was dried at ambient temperature and blocked for 1 h in PBS (7 mM 
phosphate/0.1 M NaCl buffer (pH 7.3) with 5% non-fat dried milk) (ELK, DMV Campina B.V., 
The Netherlands). Rubella E1 and E2 proteins were detected using specific mouse 
monoclonal antibodies (25 jg /m l) followed by alkaline phosphatase-conjugated goat anti­
mouse IgG (diluted 1:500) (Promega, Madison, WI, USA). The capsid protein was detected 
using a specific rabbit anti-serum (diluted 1:100) followed by alkaline phosphatase- 
conjugated goat anti-rabbit IgG (diluted 1:4 000) (Promega). Both the antibody and the 
conjugate solutions were diluted in PBS containing 0.05% Tween 20 and 0.5% non-fat dried
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milk. Immune complexes were detected using a BCIP/NBT substrate (Kirkegaard & Perry 
Labs., Gaithersburg, Maryland, USA) according to the manufacturer's instructions.
2.9 High perform ance size exclusion chrom atography
HPSEC was performed on a Superose 6 HR 10/30 column (Pharmacia) in PBS 
containing 0.05% Tween 20. The protein standards thyroglobulin 669 kDa, ferritin 440 kDa, 
catalase 232 kDa and aldolase 158 kDa (High Molecular Weight Gel Filtration Calibration 
Kit, Pharmacia) were dissolved in PBS containing 0.05% Tween 20 and used to calibrate the 
column. A sample of the rubella protein solution (100 |jl) was injected following 0.2 jm  pore 
size membrane filtration. The flow rate was 0.5 ml/min and detection was performed at 
206 nm. Micro-preparative purification was performed collecting fractions of 0.5 ml during the 
whole run.
2.10 E lectron m icroscopy
Samples of the immunoaffinity-purified rubella antigen on grids with freshly prepared 
carbon coated formvar were subjected to negative staining using a 2% (w/v) 
phosphotungstic acid solution (pH 5.2) and examined with a Philips EM 509 electron 
microscope.
2.11 Preparation o f im m unosorbent
A detailed comparison of hydrazide-, tresyl chloride- and NHS-activated agarose for 
purification of rubella E1-E2 protein complexes has been published by van Sommeren et al.
(1993). Due to its good coupling properties and the fact that it showed the lowest ligand 
leakage both during storage and chromatography in the study, NHS-activated Sepharose
4 FF was chosen for preparation of the immunosorbent.
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Approximately 12 ml of a 66% v/v NHS-activated Sepharose 4 FF gel suspension in 
isopropyl alcohol were washed twice on a sintered glass filter (first with 120 ml of 1 mM HCl, 
then with 25 ml of distilled water (4°C)). The gel was transferred to a tube using 0.2 M 
NaHC03/0.5 M NaCl buffer (pH 8.0, coupling buffer), immediately followed by addition of 
Mab RU.0T28B in coupling buffer. The final coupling conditions after optimization of ligand 
density were: 2.5 mg Mab/ml gel, 33% gel suspension, 0.2 M NaHC03/0.5 M NaCl buffer 
(pH 8.0). Incubation was performed for 1 h at ambient temperature using end-over-end 
rotation. Blocking of residual active groups was not required, as N-hydroxysuccinimide 
groups hydrolyse very fast in water. Throughout the whole incubation period, samples were 
taken from the supernatant to determine the coupling performance. In order to remove 
non-covalently bound antibodies, the gel was washed on a sintered glass filter 6 times (one 
cycle using approximately 10 bed volumes of 7 mM phosphate/0.1 M NaCl buffer (pH 7.3, 
PBS), four cycles using 0.1 M sodium acetate/0.5 M NaCl buffer (pH 4) and 0.1 M 
Na2C 0 3/0.5 M NaCl buffer (pH 11), one cycle using PBS). The gel was stored in PBS 
containing 3 mM sodium azide at 4°C.
2.12 Determ ination o f s ta tic  b ind ing capacity and b inding e ffic iency
Six different amounts of rubella antigen were incubated at pH 7.3 with 40 j l  of a 
25% v/v gel suspension of each immunosorbent. Incubation was performed by end-over-end 
rotation over a period of 16-20 h at ambient temperature. After settling of the gel, the rubella 
E1 antigen activity in the supernatant was determined by means of ELISA.
2.13 ELISA fo r quantita tive determ ination o f anti-rubella IgG
The suitability of the purified rubella antigen preparations for use in a fluorescent 
enzyme immunoassay for the quantitative determination of anti-rubella IgG in human serum 
was investigated by the following method.
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Per gram of aldehyde-activated magnetizable solid phase (Anagen Ltd., UK), 225 U of 
purified rubella antigen were coupled. The remaining active groups were blocked with BSA.
A 75 jl-volum e of solid phase suspension and 10 j l  of sample were mixed and 
incubated for 1 minute. The solid phase was washed twice and incubated with 160 |jl of 
conjugate solution (Mab anti-human IgG coupled to alkaline phosphatase) for 10 min. 
The solid phase was washed again and incubated with 300 j l  of substrate (4-methyl 
umbelliferone phosphate) for another 10 min. The fluorescence was measured at 450 nm 
(exitation wavelength 370 nm). The results were expressed in nanomoles 4-methyl 
umbelliferone per litre. The whole assay was carried out at 37°C.
3. RESULTS AND DISCUSSION
3.1 Effect o f ligand density
The static binding capacity of the immunosorbents with ligand densities of 2.9, 5.4 and
11.1 mg of Mab per ml of gel was measured batchwise according to the procedure described 
under Experimental. No binding was observed when the antigen was incubated with a gel 
which contained no ligand, which excludes non-specific adsorption. An incubation period of
16-20 h proved to be sufficient time to reach equilibrium conditions (Fig. 1). The binding 
efficiency studies show that the ligand density has hardly any effect on the binding capacity 
(for intended binding efficiencies of at least 80%) (Fig. 2). When rubella antigen activities of 
more than 2 000 U/ml gel were applied, a slight increase in static binding capacity was 
observed for growing ligand densities. However, the binding efficiency decreased to less 
than 60% under these conditions.
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Figure 1 Determination of the binding rate of rubella antigen to the immunosorbents with ligand 
densities of (■) 2.9, (▲) 5.4, and (*) 11.1 mg IgG /  ml gel. An amount of 1 000 U /  ml gel was applied; 
incubation was performed batchwise for 16-20 h at ambient temperature. The amount of unbound 
antigen was determined by ELISA.
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Figure 2 Determination of the binding efficiency of the immunosorbents with ligand densities of 
(■) 2.9, (▲) 5.4, and (*) 11.1 mg IgG /  ml gel. Rubella antigen was incubated batchwise with the 
immunosorbents for 16-20 h at ambient temperature. The amount of unbound antigen was determined 
by ELISA.
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The small effect which ligand density has on the binding capacity can be explained by 
the relatively large size of the antigen protein complexes. Most probably, only those Mabs 
which are situated on the gel particles' periphery are effective in binding the antigen. Limited 
mass transport due to the very low diffusion coefficients of the large protein complexes is 
likely to be of no consideration as an incubation period of 16-20 h at end-over-end rotation 
should be sufficient to reach equilibrium conditions (Fig. 1).
3.2 Im m unoaffin ity purifica tion
Immunoaffinity purifications started with a hemagglutinin (HA) solution (pH 8.5 - 9.0) 
which was adjusted to pH 7.3 and centrifuged for 20 min at 10 000 g. The supernatant was 
filtered through a 0.45 jm  pore size filter. A PBS suspension containing 25% v/v 
immunosorbent (ligand density of 2.5 mg Mab/ml gel) was incubated with the pretreated HA 
solution (approximately 1 000 U/ml gel). Incubation was performed batchwise by 
end-over-end rotation over a period of at least 4 h at ambient temperature or for 16-20 h 
at 4°C. After incubation, the gel was transferred to a column (0 x h = 1.0 x 10 cm) and 
washed with PBS at a flow rate of 76 cm/h until stable baselines (absorbance at 280 nm and 
conductivity) were reached. The adsorbed antigen was eluted with 0.01 M carbonate buffer 
(pH 11.0) at a flow rate of 15 cm/h. The eluted antigen fraction was neutralized with 1 M 
hepes (pH 6.5), yielding a final pH of approximately 8.5.
After 14 purifications based on this procedure, the mean yield of rubella antigen activity 
was 67% after sample treatment, whereas the mean recovery of the immunoaffinity 
purification was 76%. Contamination of the purified rubella antigen with mouse IgG was 
generally lower than 0.02% (w/w). The mean purification factor was 2 580. According to 
these data the amount of rubella E1-E2 protein in the HA starting material appeared to 
be 0.02% (w/w) of the total amount of protein.
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A higher recovery of rubella antigen activity was obtained when the sample pH was 
adjusted between 8.0 and 9.0. Maintaining this pH during the adsorption phase of the 
immunoaffinity purification had no effect on the binding efficiency (data not shown).
3.3 Determ ination o f b ind ing perform ance o f the im m unosorbent in packed bed 
experim ents
The effect of the antigen load in the sample (approximately 200 and 1 000 U rubella 
antigen/ml gel, column dimensions (0 x h = 0.5 x 5.2 cm and 1.0 x 9.0 cm) and flow rate 
during adsorption (20, 40 and 300 cm/h) were investigated. The best results with respect to 
yield and specific activity were obtained with a load of approximately 200 U of rubella per ml 
of gel and a flow rate of 40 cm/h, using a column with a diameter of 1.0 cm and a bed height 
of 9 cm (Table 1).
Table 1 The effect of sample load, column dimensions and flow rate during adsorption with respect 
to recovery of rubella E1 antigen activity during the purification process and the specific activity of the 
final product.
Adsorption 
flow rate 
(cm / h)
Activity 
offered 
(U / ml gel)
Column
dimensions
(cm)
Non-bound
activity
(%)
Yield
activity
(%)
Recovery
activity
(%)
Specific 
activity 
(U / mg)
300 936 0.5 x 5.2 57 36 93 1 030
20 800 0.5 x 5.2 23 53 76 830
300 223 0.5 x 5.2 32 60 92 650
20 225 0.5 x 5.2 14 77 91 470
20 238 0.5 x 5.2 12 85 97 490
40 209 1.0 x 9.0 6 79 85 920
40 214 1.0 x 9.0 5 74 79 840
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The reproducibility of the final purification procedure was investigated with three 
different samples of hemagglutinin. The yields obtained from isolation and purification were 
80-85% and 72-75%, respectively, resulting in a final overall yield of 57-64% (Table 2). 
The specific activity of the final product varied from 700-780 U/mg. The concentration of 
mouse-IgG in the final product was below the detection limit of the ELISA.
Table 2 Reproducibility of the immunopurification method.
Batch no. 1 2 3
HA raw material
Volume (ml) 130 200 132
Activity (U / ml) 13.4 12.9 14.0
HA after sample pretreatment
Volume (ml) 124 189 120
Activity (U / ml) 11.2 11.0 13.2
Activity yield (%) 80 84 85
Immunoaffinity purification *
Activity applied (U / ml gel) 195 291 222
Activity non-bound (%) 9 9 6
Activity yield (%) 73 72 75
Activity recovery (%) 82 81 81
Overall activity yield (%) 57 59 64
Characteristics of purified HA
Volume (ml) 23.0 23.4 23.7
Activity (U / ml) 42.9 62.4 49.9
Protein concentration (mg / ml) 0.061 0.080 0.070
Specific activity (U / mg) 700 780 710
* Chromatographic conditions: column dimensions 0  1.0 cm, h 9.0 cm (7.1 ml gel);
adsorption at pH 8.5, flow rate 40 cm / h; and desorption at pH 11.0, flow rate 300 cm / h.
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3.4 Characterization by SDS-PAGE and W estern b lo t analysis
The immunoaffinity-purified rubella preparations visible in the acrylamide gels 
(obtained under both reducing and non-reducing conditions) could be principally identified as 
rubella E1 monomeric protein, E1-E1 homodimer, E1-E2 heterodimer or E1-E2 multimer 
complexes, depending on their molecular mass and reactivity with monoclonal antibodies in 
Western blot analysis. The monomeric E2-protein and the capsid protein were not visible in 
the acrylamide gels and could be detected only by Western blot analysis (data not shown).
3.5 Characterization using EM
Electron microscopic examination revealed that the purified rubella antigen 
preparations consist of rosette-like structures with a size of 16-25 nm. These structures are 
similar to those described by Trudel et al. (1981); they used gel filtration chromatography on 
Sepharose 6B to carry out purification and obtained hemagglutinin rosettes with a size of
15 nm and a predicted molecular mass of about 850 kDa, based on a sedimentation 
constant of 26S.
3.6 Characterization using HPSEC and ELISA
HPSEC of the hemagglutinin starting material and the immunopurified preparation was 
performed as described under the methods section. The fractions collected during 
chromatography were analysed with regard to rubella E1 activity using an ELISA. In both 
preparations the fraction with the highest E-1 activity was eluted in the void volume. It had an 
apparent molecular mass of more than 669 kDa. A second fraction eluted from the column 
had an apparent molecular mass of about 300 kDa. Most probably, it is the void fraction 
which contains the rosette-like structures (15-26 nm) observed with electron microscopy. 
The 300 kDa fraction is likely to be a spike, sometimes called monomeric hemagglutinin.
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These results support the model of repeating hexamers (Mr 305 kDa) composed of five 
molecules of E1 and a single molecule of E2 as described by Waxham and Wolinsky (1985).
3.7 Determ ination o f s tab ility
Short-term stability studies (up to 8 days) showed that the HA starting material is 
relatively stable with respect to its reactivity in ELISA. Repeated freezing/thawing cycles 
showed hardly any effect. When clarification and purification is performed within 24 hours 
at 4°C or ambient temperature, no decrease in activity is to be expected.
HA purified by immunoaffinity chromatography appeared to be stable when stored 
frozen (-70°C). However, it was observed that almost all reactivity in ELISA was lost after 
three days of storage at ambient temperature. SDS-PAGE analysis showed a decrease in 
the concentration of material with a high molecular mass, while other components with a 
relatively low molecular mass emerged. This indicates that the instability is most probably 
caused by proteolytic enzyme activity. Three assays, based on different casein substrates 
were used for detection of proteolytic enzyme activity: (1) protease substrate gel tablets 
(BioRad) containing casein substrate at a pH range of 5-8.5; (2) a casein resorufin-labeled 
substrate solution at a pH of 7.8 (Boehringer Mannheim Biochemica); and (3) a succinylated 
casein substrate solution at a pH of 8.5 (Quanti Cleave Protease Assay Kit II, Pierce). 
However, none of the three assays was able to detect any proteolytic enzyme activity. When 
the protease inhibitor phenylmethylsulphonylfluoride (PMSF) was added in concentrations up 
to 0.01 mM, 94% of the reactivity in ELISA was retained after 10 days of storage at ambient 
temperature and no degradation could be observed by SDS-PAGE. Pepstatin A (0.7 |jg/ml) 
and EDTA (0.5 mg/ml) also yielded a stabilizing effect: 83% and 71% of the reactivity was 
retained after 3 days of storage at ambient temperature, respectively.
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3.8 Determination of the hemagglutination activity
The mean hemagglutination titer of the starting materials (before immunoaffinity 
purification took place) was 1/640. After immunoaffinity purification, the titer was 1/10 240. 
Considering the recovery and the concentration factor during purification, this means that the 
rubella antigen completely retained its viral hemagglutination activity.
3.9 Evaluation of purified rubella antigen in an ELISA fo r determination of anti­
rubella IgG
The immunoaffinity-purified rubella antigen was used in a fluorescent immunoassay for 
the quantitative determination of anti-rubella IgG in human serum. The obtained dose- 
response curve has a dynamic range of 10-400 IU rubella IgG/ml. The detection limit 
calculated on the basis of the mean signal plus 2 standard deviations of twenty replicates of 
an anti-rubella negative serum pool was 1.0 IU/ml.
The specificity of the assay was determined by testing 70 sera which were positive for 
anti-rubella IgG in the Rubazyme EIA (Abbott Laboratories) and 54 sera which were 
negative. The assay specificity was 100%.
Testing of sera which were negative for anti-rubella, but positive for anti-Toxoplasma 
IgG (5 sera) or IgM (2 sera) or anti-CMV IgG (5 sera) showed no interference. Testing 
of 38 sera showed that rheumatoid factor had no influence on the assay response. Since 
these results were obtained with a limited number of sera, more sera will be tested in order 
to confirm the results.
These data show that the rubella E1-E2 protein complexes purified by immunoaffinity 
chromatography are suitable for application in a fluorescent enzyme immunoassay for the 
determination of anti-rubella IgG in human serum.
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Purification of immunoglobulins from hen’s egg yolk by 
immunochromatography on immobilized hCG
A.P.G. van Sommeren, H.W.M. van den Bogaart, W.J.G. Schielen and T.C.J. Gribnau
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ABSTRACT
A rapid, simple, and reproducible method for the isolation and chromatographic 
purification of immunoglobulins against human chorionic gonadotrophin (hCG) from hen’s 
egg yolk (IgY) is described. Lipids are present in high concentrations in yolk and are the 
major problem in isolation of IgY. Their removal was performed by precipitation using sodium 
dextran sulphate. The final, one-step purification of the specific antibodies was achieved by 
immunoaffinity chromatography using hCG immobilized to N-hydroxysuccinimide-activated 
Sepharose 4 fast flow as immunosorbent.
The IgY preparations obtained were characterized using an enzyme immunoassay for the 
determination of anti-hCG activity. High performance size exclusion chromatography and 
sodium dodecyl sulphate polyacrylamide gel electrophoresis were used for determination of 
purity. The process could easily be scaled up to a batch size of one hundred eggs, yielding 
330 mg of specific anti-hCG antibody of high purity.
Key-words Immunoaffinity, Purification, Immunoglobulins, Egg yolk, hCG, IgY 
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1. INTRODUCTION
It has been known since 1893 that birds protect their offspring by accumulation of 
relatively high amounts of immunoglobulins in the yolk of their eggs [1,2,3,4,5,6]. The term 
IgY was coined for the antibody fraction which is equivalent to chicken serum IgG. Today 
many research workers and commercial companies use the yolk from eggs laid by 
immunized chickens, turkeys, or ducks as an excellent and extensive source of antibody.
Antibodies produced in chickens offer several important advantages over antibody 
production in mammals. One chicken egg contains as much antibody as an average bleed 
from a rabbit. Yolk antibodies are highly acid resistant and heat resistant [6]. The isolation of 
IgY does not require animal bleeding; thus this approach is compatible with animal protection 
regulations. Another advantage is that conserved mammalian proteins are usually more 
immunogenetic in the phylogenetically distant birds. Also, chicken antibodies are very 
suitable for use in immunoassays involving mammalian sera. They reduce interference by 
rheumatoid factors [7,8,9] and complement activation [10], and show poor cross-reactivity 
with mammalian immunoglobulins [11]. The applicability of IgY-type antibodies to 
immunological investigations has been reviewed and discussed by Schade et al. [12].
Half of the yolk consists of water and 66% (w/w) of the total amount of the solid 
components are lipids [13]. The main problem with purification of IgY from yolk compared 
with serum is this large amount of lipid present and the use of standard precipitation 
techniques is not possible.
A number of methods for the separation of proteins from lipoproteins and the 
remainder of the yolk lipids have been described in the literature [3,14,15,16,17,18]. The 
published methods were found of limited value for the routine processing of yolk, as they 
involve extraction with organic solvents resulting in rather low yields of antibody, or require 
prolonged high speed centrifugation. Still, the most frequently used isolation procedures are 
based on methods developed by Polson et al. [19,20,21] and Jensenius et al. [22]. Polson 
described a purification method for IgY from egg yolk based on polyethylene glycol
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fractionation. Jensenius described two simple and efficient extraction methods. The first 
involves the precipitation of lipids with dextran sulphate (based on the finding by 
Burstein [23]), and the second euglobulin precipitation by dilution with nine volumes of water. 
In both cases sodium sulphate fractionation was used for final purification. Several 
other procedures by which IgY antibodies can be readily extracted from egg yolk were 
described [18,24,25,26]. Also, purification kits are already commercially available 
(EGGstract™ and Gamma Yolk™).
As antibodies from egg yolk find an increasing number of applications in research 
purposes, diagnostics, and therapeutics, many purification procedures including one or more 
column chromatography purification steps have been described [27,28,29,30,31,32,33]. 
Despite this large number of purification procedures little has been reported on the final 
downstream purification using immunoaffinity chromatography for removal of the non­
specific antibodies. Carroll and Stollar [27] and Gassmann et al. [34] have described the use 
of immunoaffinity chromatography for purification of IgY antibodies. However, their aim was 
to analyse the quantity and concentration of specific antibodies in comparison to those found 
in serum. Ntakarutimana et al. [35] described a method for preparative scale purification of 
anti-human transferrin antibodies from extracts of egg yolk based on immunoaffinity 
chromatography.
In the present study antibodies against hCG, to be used in pregnancy tests, were used 
as a model for the development of an easy, fast, efficient, and reproducible downstream 
purification method, which is also applicable on a large scale. The method is based on an 
isolation procedure using sodium dextran sulphate precipitation, directly followed by a 
one-step purification of the specific antibodies by immunoaffinity chromatography.
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2. EXPERIMENTAL
2.1 Chemicals and Reagents
N-hydroxysuccinimide (NHS)-activated Sepharose 4 fast flow (FF), containing 24-25 
^mol of NHS-groups per ml of gel stored in 2-propanol, Sephadex G25, Superdex 75 and 
200 prep grade (pg) prepacked columns (0  26 mm, height 60 cm), Sephadex G25 PD-10 
columns, Ampholine PAGplate (pH range 3-10), and sodium dextran sulphate were 
purchased from Pharmacia Biotech (Roosendaal, The Netherlands). Tresyl-activated 
agarose was obtained from Pierce (Rockford, IL USA). The Zorbax GF-250 column was from 
Chrompack (Middelburg, The Netherlands). Pregnyl hCG (5 100 lU/mg) was purchased from 
Diosynth (Oss, The Netherlands). Rabbit anti-chicken IgG (H+L) conjugated to horse radish 
peroxidase (HRP) was purchased from NORDIC (Tilburg, The Netherlands). AP-20 prefilter, 
Millex GV4 0.2 ^m, and polyvinyldifluoride (PVDF) 0.2 ^m filters were obtained from Millipore 
(Etten-Leur, The Netherlands). The polysulphone 0.2 ^m capsule was from Gelman 
(Michigan, USA). Omega 30 kDa ultra-filtration membranes were purchased from Filtron 
(Breda, The Netherlands). All other chemicals were of analytical-reagent grade.
2.2 Equipment
The liquid chromatography system was supplied by Pharmacia and consisted of two 
P-500 and one P-6 000 piston pumps, an MV-7 valve, a UV-M II monitor, a FRAC-200 
fraction collector, and a flat-bed recorder. The HPLC system consisted of a Gilson 232-401 
autosampler, an LKB 2151 variable wavelength detector, and a model 160 pump module, 
analog interface, and System Gold Software from Beckman B.V. (Meijdrecht, The 
Netherlands). A microwell system (model 510 reader, model 500 incubator and a model 500 
washer) was obtained from Organon Teknika (Turnhout, Belgium). Absorbance 
measurements were performed on a Pye Unicam model 8600 or 8700 spectrophotometer.
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The Mini-Protean II electrophoresis system was purchased from Bio-Rad (Veenendaal, 
The Netherlands). A stirred ultra-filtration cell was from Amicon (Beverly, MA USA). 
The Centricon centrifuge was obtained from Kontron AG (Zürich, Switzerland).
2.3 Immunizations
Seven week-old female specific pathogen free (SPF) chickens were vaccinated in the 
leg muscle and boosted in the breast muscle with 0.25 ml of a 250 jg/m l of hCG solution, 
formulated as a water (45% w/w) in oil (paraffin base, 55% w/w) emulsion [36]. Eggs were 
collected during a period of 14 to 45 weeks after vaccination.
2.4 Determination of the Protein Content
The protein content of purified IgY solutions was determined by UV measurement. 
The concentration was calculated from the absorption at 280 nm using an extinction 
coefficient of 1.33 ml / (cm.mg) [37].
2.5 ELISA fo r Determination of anti-hCG IgY Activity
A direct two-stage sandwich ELISA was developed using hCG and an HRP-conjugated 
rabbit anti-chicken IgG (H+L). Pregnyl hCG (135 |jl 1 000 IU/ml in 50 mM sodium carbonate 
buffer, pH 9.6 per well) was coated overnight on polystyrene microtitration strip-plates at 
4°C. After removal of the coat solution the plates were post-coated with 135 j l  of 10 g/l of 
bovine serum albumin per well for 1 h and, subsequently, the plates were washed, dried, and 
stored at 4°C. Samples and standards were diluted in a 20 mM tris-HCl buffer, pH 7.2 
containing 20% (v/v) normal goat serum and 1% (v/v) Triton X-100, and incubated (100 j l  
per well) for 45 minutes at ambient temperature. The wells were washed (350 j l  per well) 
four times with 7 mM phosphate - 0.1 M NaCl buffer, pH 7.3 [phosphate buffered saline 
(PBS)] containing 0.05% (w/v) of Tween 20 (T) and incubated with 100 j l  of conjugate
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solution in PBST for 0.5 h at ambient temperature. Finally, the wells were washed and 
incubated for 0.5 h at ambient temperature with (100 j l  per well) substrate (ureaperoxide) / 
chromogen (tetra methyl benzidine) solution. The reaction was stopped by addition of 1 M 
sulphuric acid solution (100 j l  per well). Absorbances at 450 nm were determined using a 
microtitration plate reader. The measuring range of the assay was 0.025-0.25 U IgY / ml. 
Units were obtained by defining an in-house immunoaffinity-purified IgY solution with a 
concentration of 1 mg / ml arbitrarily as 1 000 U / ml.
2.6 High Performance Size Exclusion Chromatography
HPSEC analysis was used to determine the purity of the isolated IgY preparations. 
Also, the amount of hCG coupled to the Sepharose matrix was established by HPSEC 
analysis.
A Zorbax GF-250 column was equilibrated with 0.2 M sodium/potassium phosphate 
buffer pH 7.0 at a flow rate of 1.0 ml/min and detection was performed at 206 nm. 
After 0.2 |jm pore size membrane filtration, a 110 |jl volume of sample or standard solution 
was used for loading; 20 j l  was injected into the column. Purity was expressed as the 
percentage of monomeric IgY (peak area of monomeric IgY over total peak area corrected 
for salt peaks). To determine the amount of hCG coupled to the Sepharose matrix, the peak 
areas obtained for five standard solutions (2, 1, 0.5, 0.25, 0.125 mg hCG / ml in 0.2 M 
sodium/potassium phosphate buffer pH 7.0) were plotted as a function of the hCG 
concentration. The calibration line obtained was used to calculate the concentration of hCG 
in the samples. The measuring range of the assay was 0.1-2.0 mg hCG / ml.
2.7 Preparation of the Immunosorbent
Pregnyl hCG to be used as a ligand was purified by gel filtration on a Superdex 
75 prep grade column which was equilibrated in 0.2 M NaHCO3 - 0.5 M NaCl buffer, pH 8.0,
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and eluted at a flow rate of 45 cm/h. Detection was performed at 280 nm. An amount of 
500 mg pregnyl hCG was dissolved in 7 ml of 0.2 M NaHCO3 - 0.5 M NaCI buffer, pH 8.0, 
filtered through a 0.2 |jm pore size membrane filter and applied to the column. The hCG 
fraction eluting with a retention volume between 112 and 153 ml, corresponding to an 
apparent molecular weight of 139 to 45.5 kDa, was pooled and used for preparation of the 
immunosorbent.
Approximately 75 ml of a 66% (v/v) slurry of N-hydroxysuccinimide-activated 
Sepharose 4 FF gel was washed on a sintered glass filter with at least 500 ml of 1 mM HCl 
at 4°C. The residual gel (50 ml) was suspended in 50 ml of purified hCG solution (4.6 mg/ml 
in 0.2 M NaHCO3 - 0.5 M NaCl buffer, pH 8.0). Incubation was performed by end-over-end 
rotation for 22 h at ambient temperature. During and at the end of incubation, samples were 
taken from the supernatant. The amount of hCG in these samples was analyzed by HPSEC 
to determine the coupling rate and ligand density. In order to remove non-covalently bound 
hCG, the gel was washed successively with six cycles of approximately 3 bed volumes each 
of 0.1 M sodium acetate - 0.5 M NaCl buffer, pH 4.0, and 10 mM NaOH solution. Every 
alternating pH step was checked using pH indicator paper. The gel was washed with 
20 mM hepes - 0.15 M NaCl - 3 mM NaN3 buffer, pH 7.2, (binding buffer) and stored at 4°C 
until use.
2.8 Analysis of the Adsorption Characteristics
The static binding capacity was measured in batch experiments, it was determined that 
16-20 h of incubation was ample for equilibrium to be established. Six 200 j l  portions of 
a 50% (v/v) hCG-Sepharose gel suspension in binding buffer were added to 4, 10, 20, 30, 40 
and 50 ml portions respectively of anti-hCG IgY suspension. Incubation was performed by 
end-over-end rotation for 18 h at ambient temperature. After settling of the gel, the anti-hCG 
IgY activity in the supernatant was determined in an ELISA.
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The dynamic binding capacity was determined using a 1 ml column of hCG-Sepharose 
(0  5 mm, height 5 cm) equilibrated in binding buffer. A volume of anti-hCG IgY suspension 
varying from 765 to 930 ml was applied to the column at a flow rate of 229 cm/h. The column 
was washed with binding buffer, and 0.15 M NaCl solution. The bound antibody fraction was 
desorbed with 10 mM NaOH - 0.15 M NaCl solution. Detection was performed at 280 nm. 
The pH of the eluted antibody fraction was neutralized with 1 M hepes buffer, pH 6.5. 
Fractions collected during the whole chromatography procedure were analyzed for anti-hCG 
IgY activity by means of an ELISA.
2.9 Isolation of IgY from Egg Yolk
Isolation of the total immunoglobulin fraction from egg yolk was performed with some 
modifications of the procedure described by Jensenius [22]. The egg yolk and egg white 
were separated manually using a household egg-splitter or mechanically using the 
equipment of an egg processing manufactory in The Netherlands. The membranes were 
torn but not removed. One volume part (V ml) of the collected egg yolks was suspended with 
four volumes of 10 mM tris-HCl buffer, pH 7.2. A volume of 0.5 * V ml of 110 g/l of sodium 
dextran sulphate solution was added to the suspension, which was stirred for 15 minutes. 
Subsequently, a volume of 0.625 * V ml of 2 M CaCl2 was added and after resuspension 
stirring was continued for another 30 minutes. The suspension was centrifuged for 
15 minutes at 10 000 N/kg to remove the precipitated lipids. An equal volume of
2.5 M sodium sulphate solution was added to the clear supernatant to precipitate the IgY 
fraction. After centrifugation the pellet was dissolved in V ml of 20 mM phosphate buffer 
pH 7.2. The IgY solution was clarified by centrifugation for 15 minutes at 10 000 N/kg. 
The entire procedure was carried out at ambient temperature.
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3. RESULTS AND DISCUSSION
At first the total immunoglobulin fraction from egg yolk was isolated as described in the 
experimental section, followed by purification of the monomeric fraction using gel filtration on 
a Superdex 200 pg column. Evaluation of this total IgY preparation, which contained up to 
approximately 16% specific anti-hCG immunoglobulins, in an in-house pregnancy test 
showed a positive response with 1 000 IU hCG / l in urine.
To obtain a higher content of specific anti-hCG antibodies, purification was performed 
with the aid of immunoaffinity chromatography instead of gel filtration. Therefore, the IgY 
solution was prepared for immunoaffinity purification by desalting on a PD-10 column 
equilibrated in 20 mM phosphate buffer, pH 7.2. The IgY solution obtained was incubated 
batchwise with an immunosorbent (4.0 mg hCG coupled per ml of tresyl-activated agarose) 
by end-over-end rotation for 16 hours at ambient temperature. The gel was transferred to an 
empty PD-10 column and washed with 20 mM phosphate buffer pH 7.2 to remove non- 
specifically bound material. Subsequently the gel was washed with 0.15 M NaCl to obtain a 
steep pH change during desorption. After desorption with 10 mM NaOH solution the IgY 
obtained solution was neutralized with 1 M phosphate buffer pH 7.0. The yield was 2.8 mg of 
immunoaffinity-purified anti-hCG IgY per egg yolk. The purity determination, using HPSEC, 
showed 64% monomeric IgY. It seems necessary to have a solution of sufficient ionic 
strength to obtain a clear solution of the purified IgY. Addition of NaCl up to a concentration 
of 0.15 M to the desorbed fraction or to the desorption solution (10 mM NaOH) prevents 
precipitation of IgY. Evaluation of the IgY in the in-house pregnancy test showed a positive 
response with 25-50 IU hCG / l urine; however a urine blank (0 IU hCG / l) showed also a 
slightly positive response, most probably due to leakage of hCG from the immunoaffinity 
matrix. With these results the feasibility of the application of anti-hCG IgY antibodies in 
pregnancy tests was established and development of the final isolation and purification 
method was started.
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Optimization of the Isolation Procedure
In an optimized preparative process the number of steps must be minimized, so as to 
reduce the total process time. Therefore, it was investigated whether the sodium sulphate 
precipitation, including a centrifugation step, could be omitted.
Consequently, binding of IgY to the hCG-Sepharose was performed at a high concentration 
of calcium chloride. To prevent calcium phosphate precipitation, the 20 mM sodium 
phosphate - 0.15 M NaCl buffer, pH 7.2, which was used originally for equilibration and 
washing of the immunoaffinity column, was replaced by a 20 mM hepes - 0.15 M NaCl 
buffer, pH 7.2. The supernatant obtained after removal of lipids was filtered through a 
prefilter and a 0.2 jm  pore size filter before loading onto the immunoaffinity column.
From the results it was concluded that the high calcium chloride concentration did not 
affect the specific activity of the final anti-hCG IgY preparation and, thus, the binding of IgY 
to hCG-Sepharose, since 98% of the applied anti-hCG activity was bound to the column.
To prevent "column fouling", the removal of lipids becomes more important now since 
a relatively crude yolk fraction is applied to the immunoaffinity column. Optimization of the 
amount of sodium dextran sulphate and calcium chloride showed that for best results 
- a clear supernatant with complete recovery of anti-hCG activity - final concentrations of
10.1 g/l of sodium dextran sulphate and 0.24 M CaCl2 should be used.
Optimization of the Immunoaffinity Purification Method
To improve coupling and to minimize ligand leakage, based on our experience with 
antibody columns [38], hCG was coupled to NHS-activated Sepharose 4FF instead of tresyl- 
activated agarose, as described in the experimental section. The amount of hCG in the 
samples taken from the supernatant during and at the end of the coupling process was 
determined using HPSEC. The results obtained for preparation of a 150 ml batch of
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Table 1 Determination of the coupling rate and coupling efficiency of hCG to NHS-activated 
Sepharose 4FF at 4.58 mg per ml of gel.
Coupling time (h) mg hCG coupled / ml gel Coupling efficiency (%)
0.25 2.52 55
0.50 3.86 84
0.75 4.06 89
1.00 4.40 96
2.00 4.38 96
3.00 4.38 96
4.00 4.40 96
23.00 4.24 93
immunosorbent are summarized in Table 1. The coupling of hCG is very efficient (96%) and 
is complete within 1 hour. Similar results were obtained for the preparation of a 50 ml and 
a 400 ml batch of hCG-Sepharose.
Analysis of the adsorption characteristics Batchwise and packed column procedures, 
as described in the experimental section, were used to estimate the amount of 
immunosorbent needed to bind a given amount of antibody with a certain efficiency. An anti- 
hCG suspension (95 U/ml) prepared according to the optimized isolation method was used 
for this purpose. Both procedures were performed in duplicate. The adsorption curves and 
the corresponding binding efficiency curves are shown in Figure 1.
The maximum dynamic binding capacity of the immunosorbent immediately after 
preparation as read from the adsorption curve is 45.0 kU per ml gel, corresponding to a yield 
of 15.3 mg IgY per ml gel and a specific activity for the desorbed IgY fraction of 1 356 U/mg. 
Assuming a monovalent system, one molecule of immobilized hCG (Mw 40 kDa) can bind 
one molecule of antibody (Mw 170 kDa) the nominal binding capacity for this 
immunosorbent, which has a ligand density of 4.5 mg hCG per ml gel, is 19.1 mg of antibody 
per ml of gel. This means that under the dynamic conditions used the functional binding
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Antibody activity applied (kU/ml gel)
Figure 1 Determination of the adsorption characteristics of freshly prepared hCG-Sepharose. 
Binding of IgY antibodies was performed using batchwise (▲) and packed column (■) procedures.
The adsorption curves (----) and the corresponding binding efficiency curves (-----) show the amount
(kU) and the fraction (%) of antibody activity bound per ml gel as function of the amount of antibody 
activity applied (kU /  ml gel), respectively.
capacity is 80% of the nominal binding capacity. Furthermore it is concluded that for the 
conditions used in these experiments the adsorption behaviour in the batchwise procedure 
predicts very well the adsorption behaviour in a packed column.
To obtain a binding efficiency of 95% for a packed column procedure approximately 
5.0 kU have to be offered per ml gel. However, when the goal is to use the column at the 
maximum binding capacity of 45.0 kU per ml gel, one has to account for a binding efficiency 
of ± 45 - 60%. In our case the final goal was the development of a procedure in which about 
95% of the applied IgY activity was bound to the column.
Effect of pH on desorption In another experiment the tolerance of the purification 
method with respect to the pH used for desorption was investigated. A 1 ml column of the 
immunosorbent was loaded with 900 ml of egg yolk suspension and washed using standard
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Table 2 Determination of the effect of pH on desorption of the anti-hCG IgY immunoglobulins from 
the hCG-Sepharose column.
Desorbing agent Yield (mg) Spec. act. (U / mg)
10 mM Na2 CO3 buffer, pH 8.2 0.0 -
10 mM Na2 CO3 buffer, pH 9.3 0.0 -
10 mM Na2 CO3 buffer, pH 10 0.64 987
10 mM Na2 CO3 buffer, pH 11 0.53 1 322
10 mM NaOH + 0.15 M NaCl, pH 12 12.25 1 067
conditions. Desorption was performed by sequential elution with 10 bed volumes of 10 mM 
Na2CO3 buffers of pH 8.2, 9.3, 10, 11, and finally with 10 mM NaOH - 0.15 M NaCl, pH 12. 
The results in Table 2 show that a high pH, between 11 and 12, is essential for complete 
elution of the desired IgY fraction.
Effect of flow rate on performance of the immunoaffinity column The tolerance of the 
purification method with respect to the flow rate used during adsorption and desorption was 
studied regarding the yield, binding efficiency and specific activity of the purified IgY 
preparation. For each condition a volume of 30 ml anti-hCG IgY solution (666 U/ml,
2.05 mg/ml in 20 mM sodium phosphate buffer, pH 7.2 + 3 mM NaN3), isolated according to 
the modified method of Jensenius et al. [22] described in the experimental section, was 
purified on an hCG-Sepharose affinity column (0 10 mm, height 10 cm, 7 ml bed). 
The results in Table 3 show that the flow rate used during adsorption has no effect on the 
antibody activity in the non-bound fraction (98.1-99 %), which is in agreement with the 
results obtained during analysis of the adsorption characteristics. Moreover, it is shown that 
the investigated flow rate conditions during desorption have hardly any effect on the 
purification results with respect to the yield of specific anti-hCG IgY (8.1-10 mg), and the 
specific activity of the desorbed IgY preparation (1 222-1 628 U/mg).
Reproducibility and scaling up Since egg white becomes more viscous at lower 
temperature, it is important to use eggs at ambient temperature to obtain a good and easy
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Table 3 The effect of flow rate (cm /  h) on the yield (mg), binding efficiency (%), and specific 
activity (U /  mg) of anti-hCG IgY during immunoaffinity purification on a hCG-Sepharose column 
(0 10 mm, height 10 cm, 7 ml bed).
Run Adsorption Desorption Yield Binding Specific
no. flow rate flow rate efficiency activity
(cm I h) (cm I h) (mg) (%) (U I mg)
I 20 37 10.0 99.0 1 534
II 74 37 8.8 98.7 1 222
III 153 37 9.6 98.2 1 455
IV 305 37 9.5 98.4 1 623
V 305 74 9.3 98.1 1 628
VI 305 153 8.1 98.2 1 587
VII 305 305 8.5 98.1 1 442
separation of egg yolk and egg white. With regard to recovery of the yolk it is advisable to 
use eggs which are not older than six weeks, because the yolk membrane becomes weaker 
with time. It was observed that industrially separated egg yolk, has more contamination by 
egg white in comparison to manually separated yolk.
To investigate the reproducibility of the isolation and immunoaffinity purification 
procedures, three batches of IgY were purified on a 50 ml hCG-Sepharose column 
(0 26 mm, height 10 cm), using a flow rate of 305 cm/h. With the fourth batch the process 
was scaled up and purification was performed using a 200 ml hCG-Sepharose column 
(0 50 mm, height 10 cm). The flow rate used during this purification was 205 cm/h instead of 
305 cm/h (= 6 l / h) to obviate the use of the P-6000 pump at maximum pump capacity. 
The eggs used for these batches were collected during week 14 to 17 after immunization. 
A scheme of the isolation and purification procedure used for preparation of these four 
batches of IgY is shown in Figure 2. Detailed information and results with respect to recovery 
of activity, yield, specific activity and purity of the whole isolation and purification process are 
summarized in Table 4.
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ISOLATION
EGGS
separate yolk and white egg white
EGG YOLK
dilute and homogenize with 4 parts weight of
10 mM tris-HCl buffer, pH 7.2 + 0.15 M NaCl + 3 mM NaN3 
— add 0.65 ml 100 g/l of dextran sulphate per gram of egg yolk 
homogenize and incubate for 15 minutes 
— add 0.75 ml 2 M CaCl2 per gram of egg yolk 
homogenize and incubate for 30 minutes 
— centrifuge for 5 minutes at 50 000 N/kg --------- > lipid pellet + dextran sulphate
SUPERNATANT
— filtrate: prefilter and 0.2 ^m pore size filter 
YOLK SUSPENSION
PURIFICATION
hCG-SEPHAROSE COLUMN
— equilibrate in 20 mM hepes + 0.15 M NaCl buffer, pH 7.2 
use A280 and pH monitoring 
load yolk suspension onto the column 
—wash with 20 mM hepes + 0.15 M NaCl buffer, pH 7.2 
wash with 0.15 M NaCl solution 
— desorb the bound anti-hCG IgY with 10 mM NaOH + 0.15 M NaCl 
— neutralize to pH 7.2 (eg with 1 M hepes buffer, pH 6.5)
— concentrate to about 6 mg/ml (30 kDa filter)
— filtrate: 0.2 ^m pore size filter
IGY SOLUTION
store at -20°C
Figure 2 Scheme for isolation and purification of anti-hCG IgY antibodies from egg yolk. 
The entire procedure was carried out at ambient temperature.
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Table 4 Results with respect to recovery of activity, yield, specific activity and purity of the isolation 
and immunoaffinity purification process.
Preparation of starting materials for immunoaffinity purification
Batch no. 1 2 3 4
Number of eggs 32 31 26 99
Separation method manual manual mechanical manual
Yolk suspension
Total volume (ml) 1 761 1 698 1 886 7 194
Volume per egg (ml) 55 55 72 73
Activity (U / ml) 181 182 81.6 144
Total activity (kU) 319 309 154 1 036
Immunoaffinity purification
Batch no. 1 2 3 4
Column bed volume (ml) 50 50 50 200
kU applied / ml gel 6.4 6.2 3.1 5.2
a
Activity non-bound (%) 4.4 5.4 7.2 4.5
Protein yield (mg) 100 117 75 331
Yield mg IgY / ml gel 2.1 2.3 1.6 1.9
Yield mg IgY / egg 3.1 3.8 2.1 3.3
a
Activity yield (%) 38 53 64 49
Activity recovery 43 58 71 54
Specifications of purified a-hCG-IgY
Batch no. 1 2 3 4
volume (ml) 16.6 19.5 12.5 61
Protein conc. (mg / ml) 6.05 6.01 6.01 5.43
Specific activity (U / mg) 1 199 1 391 1 314 1 540
Purity [monomer IgY (%)] 67.1 66.9 72.3 66.5
a expressed as percentage from starting material (yolk suspension)
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Evaluation of these batches of purified IgY in the in-house pregnancy test showed a 
positive response with 25-50 IU hCG / l urine, without response for the urine blank.
HPSEC analysis showed that purity expressed as percentage monomeric IgY varied 
from 67 to 72%. The content of components with a molecular weight higher and lower than 
monomeric IgY was respectively 21-27% and 6-8%. As judged from sodium dodecyl 
sulphate polyacrylamide gel electrophoresis, using 4-20% Ready gradient gels, the high 
molecular components were IgY aggregates and the low molecular weight component was a 
46 kDa protein, both under reducing and non-reducing conditions. This component, which 
was neither the heavy (72 kDa) nor the light chain (28 kDa) of IgY, was reactive in western 
blotting analysis with rabbit anti-chicken IgG (H+L)-HRP conjugate.
Isoelectric focussing patterns on an Ampholine PAGplate (pH range 3-10) were similar 
for all batches. The isoelectric point of IgY, as read from the calibration curve, was in the 
pH range of 5.0 - 5.7.
Determination of column lifetime Results obtained with the 200 ml column showed 
that the immunosorbent can be used up to 40 times with virtually no effect on the binding 
efficiency. So, there was no need for the development of any in-place cleaning procedures.
Stability Using an ELISA for the determination of anti-hCG activity, it was shown that 
the raw IgY suspension, the IgY suspension after delipidation and the purified anti-hCG IgY 
solution, containing 3 mM NaN3, retained their activity after 6-7 weeks storage at 4°C.
4. CONCLUSIONS
Although some minor details with respect to the final isolation and purification 
procedure still need to be considered (e.g. increase of activity recovery, decrease of amount 
of IgY aggregates) we have shown that our procedure is reproducible and a very good 
improvement in comparison to existing methods, especially with respect to the number of 
steps and processing time.
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This procedure shows that rapid downstream processing of specific anti-hCG IgY 
antibodies can be achieved by use of a very rapid and simple isolation procedure - removal 
of the lipids by dextran sulphate precipitation including only one centrifugation step - followed 
by a one-step purification, using high speed - l inear flow rate 305 cm/h - immunoaffinity 
chromatography with hCG immobilized to NHS-activated Sepharose 4FF. The process was 
scaled up to a batch size of hundred eggs, yielding 330 mg of the specific antibody of high 
purity. Using appropriate equipment, a further scale-up to the multi-gram level seems 
feasible.
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Mouse monoclonal antibodies of the IgG1 subclass bind only weakly to protein A. The 
results in chapter 2, however, show that efficient and robust purification procedures can be 
developed when buffers with an adequately high ionic strength are used for binding the 
antibodies. The procedure will also be useful for the purification of antibodies from ascitic 
fluids whilst these contain similar concentrations of antibodies as compared to supernatants 
from protein-free dialysis module cell culture systems.
Contamination of monoclonal antibodies with bovine immunoglobulins (co-purification) 
and protein A (ligand leakage) during protein A affinity chromatography is a known 
phenomenon. Little or nothing, however, has been published about cross-contamination of 
different monoclonal antibodies, which were purified on the same protein A column. From 
the results described in chapter 3 it can be concluded that cross-contamination can occur 
when one column is used for the purification of monoclonal antibodies by protein A affinity 
chromatography. Moreover, it was shown that there are leads to decrease the level of 
cross-contamination by improvement of the regeneration procedure.
An important consideration for the development of a bioaffinity chromatographic 
process is leakage of ligand into the purified product. Both in the case of therapeutic and 
diagnostic use of the final product an extra chromatographic step is often necessary to 
remove this contamination. From the evaluation of the activated matrices described in 
chapter 4 it appears that the N-hydroxysuccinimide-activated agarose is the matrix of choice 
especially to minimize to ligand leakage. Application of this matrix to the immunoaffinity 
purification of chicken anti-hCG antibodies proved to be a crucial factor in the successful 
development of a one-step procedure (chapter 6). The same matrix was also successfully
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applied to the one-step immunoaffinity purification of rubella virus E1-E2 membrane protein 
complexes (chapter 5).
Chapter 5  describes in detail the development of a new method for purification and 
concentration of rubella virus glycoproteins for use as antigen in enzyme immunoassays. 
It also includes a method for stabilizing these polypeptides.
Chapter 6  describes the practical use of egg yolk immunoglobulins in immunoassays 
and, in detail, the procedure for the purification of chicken anti-hCG antibodies on antigen 
columns. The procedure can be adopted easily for other antibodies if specific antigens, 
which are suitable for immobilization onto a solid phase, are available. Moreover, it will be 
useful for the immunoaffinity purification of specific antibodies of hen origin on an industrial 
scale, when required.
- 106 -
Summary
This thesis deals with the investigation of several technical problems that must be 
considered carefully during the set up of preparative bioaffinity-based separation 
procedures, in particular: protein A affinity chromatography and immunoaffinity 
chromatography.
The development of a wide variety of solid supports with high porosity, high thermal, 
chemical and mechanical stability, and low non-specific adsorption, the application of spacer 
molecules between ligand and matrix, and the development of coupling chemistries to attach 
ligands through different functional groups, all led to the widespread use of bioaffinity 
chromatographic processes for the purification of biomolecules. In the introductory part, 
chapter 1, an overview of review articles and books, and the principle, nomenclature and 
history of bioaffinity chromatography are presented to acquaint the non-specialist reader with 
the field of bioaffinity chromatography. Examples of affinity chromatographic processes 
based on non-biological interactions are also given.
The objectives of the work described in this thesis were (i) the investigation of various 
aspects concerning the purification of mouse monoclonal IgG1 antibodies using protein A 
affinity chromatography, (ii) the selection of an activated matrix for the preparation of an 
immunoaffinity matrix, and (iii) the development of immunoaffinity based purification 
procedures for antibodies against human chorionic gonadotrophin from hen's egg yolk and 
for rubella virus E1-E2 membrane proteins from virus culture supernatants.
Mouse monoclonal IgG1 antibodies bind only weakly to protein A. Chapter 2  describes 
how the composition of the binding buffer, with respect to concentration and type of ion,
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improves this binding.
The antibody-containing supernatants of protein-free hollow-fibre cell culture systems 
were used as starting material. Depending on the particular monoclonal antibody, dynamic 
binding capacities of up to 20 mg antibody per ml gel could be obtained. Variation of linear 
flow rate from 10 up to 300 cm/h and temperature (4°C versus 25°C) had a slight effect on 
the dynamic binding capacity, when a high ionic strength buffer was used during adsorption. 
Through the application of optimum binding conditions, final IgG fractions with a purity of 
more than 95% monomeric IgG were obtained. As side effect of the use of binding buffers 
with high ionic strength, however, the binding of acid proteases was also promoted.
Chapter 3 deals with the set-up of a model study to determine the extent to which 
cross-contamination occurs when the same protein A column is used to purify different 
mouse monoclonal antibodies. To perform this study sandwich ELISAs were developed to 
determine low concentrations of a monoclonal antibody in solutions with relatively high 
concentrations of another monoclonal antibody.
Three mouse IgG1 monoclonal antibodies, directed against different antigens, were 
purified on the same protein A column, with chromatographic conditions applied which are 
described in chapter 2. First an antibody directed against human chorionic gonadotrophin 
(hCG) was purified followed by an antibody against a membrane protein of the rubella virus 
(Rub) and one against a component of the human immuno deficiency virus (HIV). It was 
determined that both the anti-Rub and the anti-HIV antibodies were cross-contaminated 
with 0.16% (w/w) anti-hCG and 0.04% (w/w) anti-Rub antibodies respectively.
Modification of the regeneration procedure of the protein A column, with the use of an 
elution with 0.1 M citric acid buffer pH 2 in excess of the normally used elution with 0.1 M 
citric acid buffer pH 3 decreases the level of cross-contamination.
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Chapter 4 accounts for the extent to which the coupling performance of a mouse 
monoclonal antibody onto an agarose matrix is affected by the type of coupling chemistry, 
and how the immunoaffinity matrices obtained differ with respect to ligand leakage and 
binding capacity.
Three commercially available activated supports, N-hydroxysuccinimide-, tresyl 
chloride- and hydrazide-activated agarose, were compared with respect to coupling rate and 
coupling efficiency for a monoclonal antibody against the E1 protein of the rubella virus. 
In addition, the respective matrices were compared in terms of leakage of antibody both 
during storage and chromatography. For each support the antibody was immobilized at three 
concentrations: 0, and ca. 2.5, 5.0 and 10 mg IgG per ml gel. The N-hydroxysuccinimide- 
activated support showed very fast and complete binding of the antibody. Moreover, with the 
use of this support, ligand leakage was considerably reduced during storage and 
chromatography alike as compared to both others. It was also shown that the static binding 
capacity was comparable for the N-hydroxysuccinimide- and tresyl chloride-derivatized 
agaroses and was about a factor of two lower for the hydrazide-derivatized agarose.
The immunoaffinity purification of rubella virus E1-E2 membrane protein complexes 
from extracts of cell culture supernatants is described in chapter 5. After investigation of the 
effect of ligand density on adsorption behaviour of the immunosorbent, the immunoaffinity 
purification process was optimized with regard to adsorption efficiency by adjustment of the 
flow rate, the bed height and the amount of sample loaded onto the column.
A murine monoclonal antibody directed against the E1 membrane glycoprotein of 
rubella virus was immobilized on an N-hydroxysuccinimide-activated solid phase. 
The obtained immunosorbent was used to purify rubella virus E1-E2 protein complexes from 
Tween-80 / diethyl ether extracts of cell culture supernatants containing virus particles. 
The adsorption behaviour of immunosorbents with ligand densities of 2.9, 5.4 and 11.1 mg 
monoclonal antibody per millilitre of gel was investigated through the use of batchwise
- 109 -
l-< I •  l>-
conditions. Then the immunoaffinity purification process was optimized with regard to 
adsorption efficiency by adjustment of the flow rate, the bed height and the amount of 
sample loaded onto the column. The optimized immunoaffinity purification process which 
is reproducible and relatively simple (one-step) had a yield of 73%, a concentration factor 
of 5 - 8 and a purification factor of about 2 600. No mouse IgG caused by ligand leakage 
could be detected in the immunopurified product using an enzyme immunoassay. 
High performance size exclusion chromatography, sodium dodecyl sulphate polyacrylamide 
gel electrophoresis, immunoblotting and electron microscopy showed that the 
immunopurified product contained rosette-like structures formed by complexes of E1 and E2 
proteins. The product retained its hemagglutinating activity and proved to be suitable for 
application in a fluorescent enzyme immunoassay for determination of anti-rubella IgG in 
human serum.
Chapter 6 deals with the isolation and purification of immunoglobulins against hCG 
from hen's egg yolk by immunoaffinity chromatography.
A rapid, simple, and reproducible method for the isolation and chromatographic 
purification of anti-hCG immunoglobulins from hen's egg yolk is described. Lipids are 
present in high concentrations in yolk and are the major problem during the isolation of IgY. 
Their removal was performed by precipitation through the use of sodium dextran sulphate. 
The final, one-step purification of the specific antibodies was achieved by immunoaffinity 
chromatography through the use of hCG immobilized to N-hydroxysuccinimide-activated 
Sepharose 4 fast flow as immunosorbent. The IgY preparations obtained were characterized 
through the use of an enzyme immunoassay for the determination of anti-hCG activity. 
High performance size exclusion chromatography and sodium dodecyl sulphate 
polyacrylamide gel electrophoresis were used for determining purity. The process could 
easily be scaled up to a batch size of one hundred eggs, yielding 330 mg of specific 
anti-hCG antibody of high purity.
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PREPARATIEVE BIOAFFINITEITSCHROMATOGRAFIE 
Immuun- en proteïne A affiniteitschromatografie
Dit proefschrift behandelt het onderzoek van verschillende technische problemen 
waarmee men rekening moet houden bij de ontwikkeling van op bioaffiniteit gebaseerde 
preparatieve scheidingstechnieken; in het bijzonder proteïne A affiniteitschromatografie en 
immuunaffiniteitschromatografie.
De ontwikkeling van een grote verscheidenheid aan vaste dragers met een hoge 
porositeit, hoge thermische, chemische en mechanische stabiliteit, en een laag niet-specifiek 
adsorptiegedrag, de toepassing van spacer moleculen tussen ligand en dragermateriaal, 
en de ontwikkeling van koppelingschemie om liganden via verschillende functionele groepen 
te immobiliseren, maakten samen een brede toepassing mogelijk van bioaffiniteits- 
chromatografie voor de zuivering van biomoleculen.
In de inleiding, hoofdstuk 1, wordt een opsomming gegeven van overzichtsartikelen en 
boeken, en het principe, de nomenclatuur en de geschiedenis van de bioaffiniteits- 
chromatografie. De bedoeling is om de lezer die minder bekend is met dit terrein hierin te 
introduceren. Er worden voorbeelden gegeven van bioaffiniteitschromatografie, 
chromatografie die gebaseerd is op specifieke en reversibele interactie tussen de moleculen 
van een biologisch functioneel paar. Tevens worden er voorbeelden gegeven van 
affiniteitschromatografische processen die gebaseerd zijn op niet-biologische interacties.
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De doelstellingen van het in dit proefschrift beschreven onderzoek waren: (i) het 
onderzoeken van verschillende aspecten die betrekking hebben op de zuivering van muis 
monoklonale IgG1 antistoffen m.b.v. proteïne A affiniteitschromatografie, (ii) de selectie van 
een geactiveerd dragermateriaal voor de bereiding van een immuunaffiniteitsmatrix, en (iii) 
de ontwikkeling van op immuunaffiniteit gebaseerde zuiveringsprocedures voor antistoffen 
tegen humaan chorion gonadotrofine (hCG) uit de dooiers van kippeneieren en voor rubella 
virus E1-E2 membraaneiwitten uit celkweek supernatanten.
Muis monoklonale IgG1 antistoffen binden slechts zwak aan proteïne A. Hoofdstuk 2  
beschrijft hoe door een adequate samenstelling van de bindingsbuffer, met betrekking tot de 
concentratie en het type ion, de binding van deze antistoffen aan proteïne A verbeterd wordt.
De antistoffen werden geïsoleerd uit supernatanten van eiwitvrije holle vezel 
celkweeksystemen. Afhankelijk van de monoklonale antistof werden bindingscapaciteiten tot 
20 mg antistof per ml gel verkregen. Bij gebruik van een bindingsbuffer met hoge ionsterkte 
tijdens het adsorptieproces hadden variaties in de lineaire elutiesnelheid van 10 tot 
300 cm/uur en temperatuur (4°C ten opzichte van 25°C) een gering effect op de dynamische 
bindingscapaciteit. Bij het gebruik van optimale bindingsomstandigheden werden IgG 
fracties verkregen met een zuiverheid van meer dan 95% monomeer IgG. Echter als 
neveneffect van het gebruik van bindingsbuffers met hoge ionsterkte werd ook de adsorptie 
van zure proteases bevorderd.
De beschreven methode zal ook bruikbaar zijn voor de zuivering van antistoffen uit 
ascitesvloeistoffen, omdat deze in het algemeen een concentratie antistof bevatten die 
vergelijkbaar is met die in de hier gebruikte supernatanten van holle vezel 
cel kweeksystem en.
Contaminatie van antistof oplossingen met runder immuunglobulinen (co-zuivering) en 
proteïne A (cross-contaminatie) is een bekend fenomeen. Er is echter nauwelijks of geen
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informatie beschikbaar m.b.t. de verontreiniging van antistof oplossingen door cross- 
contaminatie veroorzaakt doordat de zuivering met dezelfde proteïne A kolom werd 
uitgevoerd. Hoofdstuk 3 beschrijft de resultaten van een modelstudie die vaststelt in welke 
mate er in zo'n situatie cross-contaminatie plaatsvindt. Om deze studie uit te kunnen voeren 
werden sandwich ELISAs ontwikkeld waarmee lage concentraties van een monoklonale 
antistof gemeten kunnen worden in oplossingen met een relatief hoge concentratie van een 
andere monoklonale antistof.
Drie muis IgG1 monoklonale antistoffen, gericht tegen verschillende antigenen, werden 
gezuiverd m.b.v. dezelfde proteïne A kolom. Eerst werd een antistof gericht tegen humaan 
chorion gonadotrofine gezuiverd, gevolgd door een antistof tegen een membraaneiwit van 
het rubella virus en een antistof gericht tegen een komponent van het humaan 
imuundeficiëntie virus (HIV). Er werd cross-contaminatie vastgesteld van zowel de anti­
rubella als de anti-HIV antistoffen, en wel met respectievelijk 0,16% (w/w) anti-hCG 
en 0,04% (w/w) anti-rubella antistoffen.
Aanpassing van de regeneratieprocedure van de proteïne A kolom, door naast de 
gebruikelijke elutie met 0,1 M citroenzuurbuffer pH 3 een extra elutie met 0,1 M 
citroenzuurbuffer pH 2 uit te voeren, verlaagt het niveau van cross-contaminatie. 
Mogelijkheden voor een verdere verbetering van de regeneratieprocedure zijn zeker nog 
aanwezig.
Een belangrijke factor om rekening mee te houden tijdens de ontwikkeling van een 
bioaffiniteits chromatografisch proces is verontreiniging van het uiteindelijke produkt door 
lekkage van de ligand. Zowel voor therapeutische als diagnostische toepassing van het 
uiteindelijke produkt is vaak een extra zuiveringsstap noodzakelijk om deze contaminant te 
verwijderen. In hoofdstuk 4 wordt beschreven in welke mate de koppeling van een 
monoklonale antistof aan een agarose matrix wordt beïnvloed door de gebruikte
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koppelingschemie, en hoe de verkregen immuunaffiniteitsmatrices verschillen m.b.t. ligand 
lekkage en bindingscapaciteit.
Drie commercieel verkrijgbare geactiveerde dragermaterialen, N-hydroxysuccinimide-, 
tresylchloride- and hydrazide-geactiveerde agarose, werden met elkaar vergeleken met 
betrekking tot koppelingssnelheid en koppelingsefficiëntie voor een monoklonale antistof, en 
lekkage van deze antistof zowel tijdens de opslag als het gebruik van de affiniteitsmatrix. 
De N-hydroxysuccinimide geactiveerde drager vertoonde een zeer snelle en volledige 
koppeling van de aangeboden antistof, die gericht is tegen het E1 membraaneiwit van het 
rubella virus. Bovendien was voor deze affiniteitsmatrix de ligand lekkage gedurende zowel 
de chromatografie als tijdens opslag aanzienlijk minder dan voor de beide anderen. 
De statische bindingscapaciteit was vergelijkbaar voor de N-hydroxysuccinimide- en 
tresylchloride-geactiveerde agarose en ongeveer een factor twee lager voor de hydrazide- 
geactiveerde agarose.
Het gebruik van de N-hydroxysuccinimide-geactiveerde matrix bleek een belangrijke 
factor voor het slagen van de ontwikkeling van een één-staps zuiveringsproces voor 
kippenantistoffen (hoofdstuk 6). Dezelfde matrix werd ook met succes gebruikt in de 
ontwikkeling van een één-staps zuiveringsmethode voor rubella virus E1-E2 membraan- 
eiwitten (hoofdstuk 5).
Hoofdstuk 5  beschrijft in detail de ontwikkeling van een nieuwe methode voor de 
zuivering en concentratie van rubella virus glycoproteïnen voor gebruik als antigeen in 
immunoassays.
Een muis monoklonale antistof tegen het E1 membraaneiwit van het rubella virus werd 
geïmmobiliseerd aan een N-hydroxysuccinimide-geactiveerde agarose matrix. De verkregen 
immuunaffiniteitsmatrix werd gebruikt voor de zuivering van E1-E2 eiwitcomplexen uit 
Tween-80 / diethylether extracten van virusdeeltjes bevattende celkweeksupernatanten. Het 
adsorptiegedrag van de immuunaffiniteits-matrices met liganddichtheden van 2,9 5,4 en
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11,1 mg antistof per ml gel werd onderzocht tijdens het gebruik onder batchgewijze 
condities.
Na onderzoek van het effect van de liganddichtheid op het adsorptiegedrag van de 
affiniteitsmatrix werd het zuiveringsproces geoptimaliseerd m.b.t. bindingsefficiëntie door het 
aanpassen van de elutiesnelheid, de bedhoogte van de kolom en de hoeveelheid monster 
waarmee de kolom beladen werd. Het geoptimaliseerde zuiveringsproces heeft een 
opbrengst van 73%, een concentratiefactor van 5 tot 8 en een zuiveringsfactor van circa 
2 600. Het proces is reproduceerbaar en relatief eenvoudig. Met behulp van een enzym 
immunoassay kon er geen muis IgG aangetoond worden in het gezuiverde produkt, als 
gevolg van ligand lekkage. Hoge druk gelfiltratiechromatografie, natrium laurylsulfaat 
polyacrylamide gelelectroforese, immunoblotting en electronenmicroscopie toonden aan dat 
het gezuiverde produkt bestaat uit roset-achtige structuren die opgebouwd zijn uit de E1 en 
E2 membraaneiwitten. Het gezuiverde produkt behield zijn heamagglutinerende activiteit en 
was geschikt voor toepassing als antigeen in een fluorescentie enzym immunoassay voor de 
bepaling van anti-rubella IgG in humaan serum.
Hoofdstuk 6  beschrijft de ontwikkeling van een nieuwe methode voor de zuivering van 
polyklonale antistoffen uit kippeneieren (IgY) met behulp van geïmmobiliseerd antigeen en 
het gebruik van deze antistoffen in de ontwikkeling van een immunoassay.
Lipiden zijn in hoge concentratie aanwezig in eierdooiers en vormen een belangrijk 
obstakel bij de zuivering van de antistoffen hieruit. De lipiden werden verwijderd door middel 
van precipitatie met natrium dextraansulfaat. Zuivering van de specifieke antistoffen, gericht 
tegen het zwangerschapshormoon humaan chorion gonadotrofine , werd bewerkstelligd door 
immuunaffiniteitschromatografie met behulp van hCG gebonden aan N-hydroxysuccinimide 
Sepharose 4 fast flow. De activiteit van de gezuiverde IgY preparaten werd bepaald met 
behulp van een immunoassay. De zuiverheid werd bepaald met hoge druk 
gelfiltratiechromatografie en natrium laurylsulfaat polyacrylamide gelelectroforese.
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Het proces werd opgeschaald tot een batchgrootte van honderd eieren. De opbrengst 
hiervan bedroeg 330 mg specifieke anti-hCG antistoffen met een hoge zuiverheid.
De beschreven methode is makkelijk aan te passen voor de affiniteitszuivering van 
andere antistoffen, indien specifieke antigenen, die geschikt zijn voor het immobiliseren aan 
een vaste drager, voorhanden zijn. Indien gewenst kan de methode verder opgeschaald 
worden voor de zuivering van specifieke kippenantistoffen op industriële schaal.
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